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Feature Selection for Identification of
Transcriptome and Clinical Biomarkers for




This study attempts to find good predictive biomarkers for recurrence
in colon cancer between two data sources of both mRNA and miRNA ex-
pression from frozen tumor samples. In total four datasets, two data
sources and two data types, were examined; mRNA TCGA (n=446),
miRNA TCGA (n=416), mRNA HDS (n=79), and miRNA HDS (n=128).
The intersection of the feature space of both data sources was used in the
analysis such that models trained on one data source could be tested on
the other. A set of wrapper and filter methods were applied to each
dataset separately to perform feature selection, and from each model the
k best number of features was selected, where k is taken from a list of set
numbers between 2 and 250. A randomized grid search was used to opti-
mize four classifiers over their hyperparameter space where an additional
hyperparameter was the feature selection method used. All models were
trained with cross validation and tested on the other data source to de-
termine generalization. Most models failed to generalize to the other data
source, showing clear signs of overfitting. Furthermore, there was next to
no overlap between selected features from one data source to the other,
indicating that the underlying feature distribution was different between
the two sources, which is shown to be the case in a few examples. The
best generalizing models where based on clinical information and second
best was on the combined feature space of mRNA and miRNA data.
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1 State of the Art
Machine learning has seen a spike of interest and development in the last decade.
Increased computational power combined with easier and cheaper data collection
and storage has lead to large datasets being available and a number of differ-
ent approaches developed to solved a wide variety of tasks. One such field of
research is oncology where transcriptome data has become more available and
researches are attempting to find good prognostic indicators for survival and
cancer recurrence, also known as relapse. This study will focus on the second
most prevalent cancer [1], colon cancer, and predicting recurrence. Predicting
recurrence is preferred over overall survival given that colon cancer patients are
in general quite old, the median age being 73 years in Norway, chapter 2.1 [1].
This means that overall survival can sometimes be problematic given patients
die of other causes than the cancer.
The most common prognostic indicators in clinical applications for colon
cancer is the Tumor-Node-Metasasis-stage (TNM-stage), which is used to de-
termine follow-up treatment post surgery [24]. Studies have determined other
relevant clinical parameters that can be used as prognostic indicators. A re-
cent study found a simple prognostic score based on six clinical parameters for
metastasised colon cancer patients [35]. Other studies have implicated DNA
Mismatch Repair (MMR) deficiency, or Microsatellite Instability (MSI), corre-
lation with survival in stage 1 and 2 patients [24]. The only molecular markers
used in clinical cases as of today are MSI-status [24], BRAF [9], and KRAS [10],
where the latter two are only used in metastatic cases.
Prognostic indicators, however, need not be specific clinical variables. Skrede
et al. trained a variant of the MobileNetV2 [44] architecture to predict presence
of a tumor based on images of stained tumor tissue [49] showing statically sig-
nificant results for good prognosis post surgery. Guinney et al. [20] considered
another approach, performing a Markov clustering of six different predictive
models output on messenger RNA (mRNA) data. The study identified four
consensus molecular subtypes of colon cancer, each characterised by specific
gene expression.
However, this study will focus on gene expression signature, messenger RNA
(mRNA) and micro RNA (miRNA), transcriptome data, clinical data, and
briefly infiltration estimates [31]. By using the transcriptome counts we can
indirectly estimate the presence of proteins that promote cancerous behaviour
or suppress anti-cancerous behaviour in cells. A number of different approaches
have been attempted, however, each approach has to deal with three core prob-
lems. 1) the high dimensionality of the data combined with 2) lower sample size,
and 3) class imbalance, about 25% of patients experience. The three problems
combined prove particularly challenging and models are prone to overfitting.
The following two papers dealt with the high dimensionality by performing sin-
gle step l1 weight decay regression models on miRNA data to determine a sixteen
[23] and four [24] miRNA prognostic indicator, respectively. However, a single
weight decay feature selection model is prone to overfitting and selecting biased
features. One approach to solve this selection problem is to explore the feature
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space with many small trained models, as done in [47]. The researches used a
Grasshopper optimization technique to generate small subsets of features that
was trained using an SVM model to perform feature selection. This approach
is a hybrid method that utilizes a methauristic optimization algorithm.
The process is divided into two steps, first selecting a subset of features
based on a number of different feature selectors, then train models on those
feature subsets. The feature selection is done with filter and wrapper methods,
the latter training models with weight decay regularization to select features.
Four classifiers are trained on the subset of selected features on each dataset
and tested on the other data source. The goal is to find a set of genes that
have high predictive power for determining recurrence, and preferably as small
of a set of genes as possible. Smaller subsets of genes lead to less likelihood
of overfitting to additional noisy and unimportant features. Furthermore, with
fewer genes relevant for the model, it would be easier in a clinical setting to use
those genes as a prognostic biomarker, rather than recording gene counts for a
large number of possible genes.
Section 2 details the relevant cellular and cancer biology background, in
addition to detailing machine learning principles and the models used for the
thesis. The methodology, experiments, and datasets will be outlined in section
3. Lastly the results of each of the experiments will be presented in section 4
and possible improvements in section 5.
2 Introduction to Cellular and Cancer Biology
and Machine Learning
The following section will detail general principles of Cellular and Cancer Bi-
ology and Machine Learning that are relevant background information for the
thesis. Section 2.1 will go through the general mechanisms of the Cell Life Cycle,
programmed cell death (Apoptosis), and mRNA and miRNA function in protein
transcription and translation. The information follows closely chapter 6, 7, and
18 of the following course book in biology [3]. Section 2.2 will briefly mention
the hallmarks of cancer, as detailed in [21], and the concept of oncogenes. Sec-
tion 2.3 will go through the general principles of Machine Learning from what
defines a model learning, performance measures, Bias-Varaince tradeoff, and
into methods of mitigating said tradeoff in Cross Validation, Regularization,
and Feature Engineering. Lastly section 2.4 and 2.5 will introduce the relevant
filter methods and classifiers used for this thesis.
2.1 Cellular Biology
Before dwelling into the details of the fundamental mechanisms of cancer, this
thesis will detail some basic principles as part of cellular biology that is pertinent
to both the discussion of said fundamentals, but also relevant to describe what
the datasets for this study. This section will firstly outline the mechanisms of
cell proliferation by detailing the different stages, and control mechanisms, of
5
the cell life cycle and also the mechanism of programmed cell death (apoptosis).
Finally a brief explanation of the translation and transcription of proteins and
how both messengerRNA (mRNA) and microRNA (miRNA) are part of that
process.
2.1.1 Cell Life Cycle
Eukaryotic cells, that is cells with an enclosed nucleus, divides into two daughter
cells through a four phase process; Gap 1 (G1), Synthesis (S), Gap 2 (G2), and
Mitosis (M). However, a cell can enter a resting state (quiescence), known as
Gap 0 (G0), temporarily, or permanently, stopping the cycle. The transition
between the four phases are driven by a series of Cyclin Dependant Kinases
proteins (Cdk) that are activated when binding to a cyclin protein. Each Cyclin-
Cdk pair is associated with promoting a transition from one step to another,
for instance the G1S-Cdk promotes the transition from G1 to S.
Within a single phase there are checkpoints that need to be passed before the
cell continues to the next phase. These checkpoints determine if all preparations
has been made for the next phase, and if not halting the transition process.
For instance to pass the G1 checkpoint the cell first checks if there is any DNA
damage. If there is some DNA damage, it actives transcription of Cdk inhibiting
proteins that halt the transition to the S stage.
In the S phase the cell replicates its DNA and preventing replication from
occurring more than once. Due to the structure of the ends of the DNA strands
the whole strand cannot be replicated, hence a small section is lost for each
replication. Because of this problem, the ends of each chromosome has a set of
non encoding genes called Telomeres. The cell has machinery that can detect
when its Telomeres is sufficiently degraded and thus stops replicating, acting as
a limit on the number of cell divisions a cell can undergo. Section 2.2.2 will go
into more detail on the impact of Telomeres in cancer.
2.1.2 Apoptosis
Apoptosis is the process of controlled cell death. Once the apoptosis has started
it is irreversible. The process can be initiated either through intrinsic or extrinsic
pathways, however, in both cases the same underlying mechanisms are triggered.
Enzymes called caspases are activated that dismantle the organelles and proteins
in the cell. The cell changes its cell surface, which attracts the attention of
specialised phagocytic cells that engulf the remains of the cell. This way the
components of the cell does not spill out onto other cells causing an inflammatory
response and parts of the cell can be recycled by the phagocytic cell. The
intrinsic pathways are generally regulated by the Bcl2 family of proteins while
the extrinsic pathways are generally either due to Tumor Necrosis Factors (TNF)
or Fas receptors.
Apoptosis is used as a means to control cell proliferation beyond just con-
trolling cell division. Section 2.2.2 will go into more detail on the impact of
apoptosis in cancer.
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2.1.3 RNA and RNA Transcription
RNA is a single stranded neucleic acid strand molecule that uses the Uracil base
instead of Thymine. Given its single stranded structure it can perform more
roles than simply storing information because it can fold and form structures.
Because of this RNAs can perform a wide variety of different roles like structural,
regulatory, and catalytic roles. The RNA strands are transcribed from sections
of DNA through the process of DNA polymerases.
2.1.4 Messenger RNA (mRNA)
For the purposes of this thesis the main focus is on protein encoding mRNAs.
Those mRNAs are transcribed from DNA as pre-mRNA, then modified and
transported to the cytoplasm for translation into proteins. pre-mRNAs consists
of introns (non encoding regions) and exons (encoding regions) that is modified
prior to translation. The introns are removed and the exons rearranged to form
an mRNA molecule that encodes a specific protein. Because the exons can be
rearranged, it means that a single gene can encode different proteins depending
on how those exons are combined. Each mRNA can be translated into proteins
multiple times, depending on the longevity of the mRNA while in the cytoplasm.
2.1.5 Micro RNA (miRNA)
miRNAs are small non-coding RNAs, about 22 nucleotides long, that are pack-
aged with a specialized protein forming a RNA-inducing silencing complex
(RISC), which searches for complementary base pair mRNAs in the cytoplasm
to induce degradation of the mRNA. The RISC does not, however, get degraded,
thus it can search for new mRNAs to silence. This means that miRNA can quite
efficiently inhibit translation of certain proteins. However, a single miRNA need
not only target a specific mRNA. As long as a mRNA contains the matching
sequence a miRNA can block translation from that mRNA.
2.1.6 Estimate of Protein Expression
The mechanisms that govern cell division, apoptosis, and relevant hallmarks
of cancer, as discussed in 2.2.2, are controlled by protein expression. Protein
expression, however, is more difficult to estimate, hence encoding mRNAs and
miRNAs are used as an estimate of the encoded, or silenced, protein. Note
that the estimate is not a one to one correlation, given that a single mRNA
can encode different proteins depending on how exons are ordered, translate
multiple instance of a single protein depending on its longevity, and a single
miRNA can silence multiple instances of mRNA molecules.
2.2 Cancer Biology
Cancer is fundamentally a tissue based disease where the regulation of cell prolif-
eration and inhibiting factors leading to continued growth and structural dam-
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age to the tissue. This imbalance in regulation comes from several different
biological mechanisms that take place in a cell or part of intercellular processes.
This section will detail some of the important mechanisms that explains how
cancer develops, grows, and spreads, and introduce the specific cancer type
relevant for this thesis, namely Colon Cancer.
2.2.1 Oncogenes
Genes that promote cancerous behaviour after being mutated are referred to as
oncognees. An oncogene could for instance promote cell growth or inhibiting
apoptosis. Most oncogenes begin as a proto-oncogene, a gene that could, once
activate, act as an oncogene. It is through the protein encoding of these genes
that the cancerous behaviour is expressed. For instance p53 regulates DNA
damage repair, however, a mutation in the encoding for p53 has been shown to
be significant in different types of cancers.
Proto-oncogenes can become oncogenes with only a small modification in
its original function. There are three primary ways of activation; mutation,
increased expression, and chromosomal translocation. A mutation in the proto-
oncogene could change the structure of the encoded protein causing a loss in
its original regulation. Increased expression could come from interactions with
other proteins or for instance downregulation of certain miRNAs that down-
regulate said protein. Lastly chromosomal translocation involves the specific
gene being translocated to a different region and/or merged with another gene,
which could lead to a change in expression. In addition to oncogenes there
are genes coined anti-oncogenes, or tumor suppressor genes, that encode regu-
lation of cell division and survival that promote cancerous behaviour by being
downregulated.
2.2.2 Hallmarks of Cancer
The following paper from 2011 details the current known 6 biological hallmarks
that define cancer in addition to outlining two possible emerging hallmarks and
two enabling mechanisms [21]. The following section will briefly introduce these
key hallmarks of cancer.
A tumor requires obtaining sufficient signals to promote, and continue, cell
division, spreading, and to evade apoptosis. The hallmarks of cancer revolve
around these two fundamental principles. Firstly, as detailed in section 2.1.1,
cells cannot divide forever as their telomere genetic code gets shortened for ev-
ery DNA sythesis the cell goes through. Additionally, the protein telomerases
can prolong the period for which a cell can continue to divide without shrinking
its telomeres. This replicative immortality is a core hallmark of cancer and con-
sidered a necessary condition for cancer development. Without this feature, a
cell would either go into senescene, and stop replicating, or undergo apoptosis.
It has been shown that shortening the telomeres in mice have a direct correla-
tion to reducing the risk of cancer development and that the lack of telomerases
may prevent neoplastic development past a microscopic state. However, the
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telomerases protein does not only function as a means of providing replicative
immortality, as it has been shown to have an impact on enhancing cell prolifer-
ation, resisting apoptosis, DNA damage repair system, and RNA polymerases
function for transcription of RNA.
However, the immortalized cells still need to stimulate proliferation and
evade growth suppressing functions. Both can occur via an intrinsic pathway
or get extrinsic pathway from other cells, for instance the supportive stromal
cells. Growth suppressor factors are part of the cell life cycle control system
outlined in section 2.1.1, namely the cyclin-Cdks, where the upregulation of
specific cycline-Cdks have a direct impact on the progression through the cell
phases for cell division. For instance, the protein p53 suppress the continuation
to the S phase when there is a sufficient amount of DNA damage in the cell,
and in extreme cases inducing apoptosis provided the damage is not repairable.
p53 can also react to other stress and abnormalities in the cell function. On
the other hand retinoblastoma (RB) is a external growth suppressors that also
impacts cell proliferation, activating senescene, or inducing apoptosis. Studies
have shown that the growth suppressing functions have a degree of redundancy,
as Rb negative and p53 negative mice, that is mice without the presence of the
gene encoding the relevant protein, developed normally, however, experiencing
abnormal developments later in life.
To sustain this continued growth, the tumor needs nutrients and energy. To
facilitate the continued expansion, the process of angiogenesis, development of
new blood vessels, have been shown to be of vital importance. An inducer of
angiogenesis is vascular endothelial growth factor-A (VEGF-A) that encode the
development of new blood vessels and the homeostatic survival of endothelial
cells. However, the produced vessels by angiogenesis are abnormal, usually
containing convoluted and excessive branching, distorted and enlarged vessels,
erratic flow, and leakiness. Studies on mice have shown that upregulation of
angiogenesis inhibitors impair tumor growth, while a downregulation increases
growth of both planted and naturally developed tumors.
In addition to angiogenesis to sustain continued growth, cancer cells repro-
gram their metabolism to support further growth. Ordinarily glycolysis is used
in anaerobic metabolism, however, cancer cells use glycolysis despite working
under aerobic conditions, leading to a state of ”aerobic glycolysis”. This change
in metabolism leads to a drastic reduction in efficiency of ATP production, that
the cell offsets partly by upregulation of glucose transporters, however, the gly-
colysis servers other purposes as well. It is hypothesised that the glycolytic
is diverted to biosythetic processes that generate nucleotides and amino acids,
facilitating more DNA synthesis.
Beyond growing, cancer tumors need to resists induced cell death. Sec-
tion 2.1.2 introduce the general principles of apoptosis, which is induced either
through intrinsic (Bcl-2 family of proteins) or extrinsic pathways (Fas ligand/re-
cepters or TNF). Protein p53 is a tumor suppressor gene that is associated with
DNA damage that halts transition from G1 to S stage of cell divison, but it can
also induce apoptosis if there is too much DNA damage to repair. Limiting the
presence of p53 is the most common strategy to resist induced apoptosis. It has
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also been shown that the intrinsic pathway is more widely implicated in halting
carcinogenic development over the extrinsic pathway.
Lastly tumors can spread to other tissue either through invasion of nearby
tissue or metastasis to spread to distant tissue through the circulatory or lym-
phic system. A key component for invasion or metastasis is ”colonization”, the
process in which a microscopic tumor can grow within the new environment to
a macroscopic tumor. Provided there is no facilitating growth factors, or other
microenvironments, that cancer cells require to pass beyond microscopic tumor,
they may revert to a noninvasive state. That is the metastasis have been able
to ”physically disseminate”, however, unable to ”adapt” to the foreign environ-
ment. Alternatively the microscopic tumor could be dormant and erupt later
after the primary tumor has been dealt with. However, in the early stages of the
invasion-metastasis cascade, a multistep process detailing invasion and metas-
tasis progress, proteins or supporting cells can have an impact on the process of
infiltrating new tissue. For instance E-cadherin, a cell to cell adhesion molecule,
that creates a cell sheet of quiescence cells limiting invasion and metastasis. It
has been show that downregulation and mutational inactivation of E-cadherin is
present in human cancers. On the opposite end stromal cells, through secreting
CCL5, can stimulate invasive behavior. Similarly a buildup of inflammatory
cells near its boundary of a tumor can produce the necessary enzymes for inva-
sion, such that the cancer cells need not produce the activating proteins of the
ephithelial-mesenchymal transition (EMT) program, a regulatory program that
is casually important for invasion and metastasis and resisting apoptosis.
Of the key hallmarks mentioned above, the paper [21] notes two enabling
hallmarks that facilitate the expression of those mentioned. The first being a
change in metabolism to support further growth. Ordinarily glycolysis is used in
anaerobic metabolism, however, cancer cells use glycolysis despite working under
aerobic conditions, leading to a state of ”aerobic glycolysis”. This change in
metabolism leads to a drastic reduction in efficiency of ATP production, that the
cell offsets partly by upregulation of glucose transporters, however, the glycolysis
servers other purposes as well. It is hypothesised that the glycolytic is diverted
to biosythetic processes that generate nucleotides and amino acids, facilitating
more DNA synthesis. Secondly is genome instability and mutations that directly
impact the underlying regulatory mechanisms/pathways and proteins for each
of the hallmarks. During the process of tumorigenesis cancer cells often increase
the rates of mutations, one of the most common ways by downregulating p53.
Additionally, the mutations can compromise the cell control system that leads
to apoptosis or senescence.
2.2.3 Colon Cancer
Colon cancer (CC), or colorectal cancer, is a cancer developed in either the colon
or rectum that ranks as the second most prevalent cancer among women and
third among men, the median age being 73 in Norway, chapter 2.1 [1]. There are
many risk factors, among which are age, dietary, and obesity, with a about 15-
30% being hereditary having some major hereditary component [17]. Despite
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comprising of a small portion of the total patient population, the heraditary
cases are studied to understand the underlying mechanism better. Of note is
the mutation in the Adenomatour Polyposis Coli (APC) tumor suppressor gene
is a contributing factor in Familial Adenomatous Polyposis (FAP), a subtype
of colon cancer that develops at a young age [17]. Others gene mutations like
KRAS [10], BRAF [9], PIK3CA [38], and TP53 [17], the gene that governs the
p53 protein, have also been shown to be relevant biomakers for colon cancer.
Together APC, KRAS, BRAF, and TP53 account for nearly 70% of all colon
cancer cases [2].
A key prognostic factor of colon cancer is the Tumor, Node, and Metastasis
Staging (TNM-Stage). The staging consists of four main stages dependant on
the independent Tumor, Node, and Metastasis stage. Principally TNM stage
1 is defined by small and local tumors. Stage 2 defined by not having spread
to lymph nodes. Stage 3 is defined by spread to lymph nodes. And stage 4 is
defined by metastasis.
The tumor stage differentiates between how many specific layers of tissue
has been penetrated by the tumor, ranging from growing through the inner
lining, muscle, outer lining, and further into a different organ. The node stage
differentiate how many lymph nodes the cancer has spread to. Lastly the metas-
tasis stage differentiate if the tumor has spread to a distant organ or not. As
mentioned above, any metastasis means that the TNM-stage is stage 4. A more
detailed explanation of the TNM-staging can be found in [13].
Standard treatment for colon cancer is surgery to remove the primary tu-
mor. Most patients are cured by the surgery, however, some develop recurrence.
Adjuvant chemotheraphy is a possible followup treatment aimed at eradicating
micrometastases, chapter 9.6 [1]. In Norway stage 3 patients are treated with
adjuvant chemotherapy, however, only specific high risk stage 2 patients get the
same treatment. The type of chemotheraphy is a combination of fluorouracil
(5-FU), folinat (FLV-regimen) and oxaliplatin (FLOX), however, 5-FU based
chemotherapy is not used for MSI-H patients. Research has shown that MSI-H
patients have no effect on those patients [45, 46].
2.3 Machine Learning
The topic of Machine Learning is dedicated to problem solving by replicat-
ing/simulating the process of ”learning” based on observations, data, and/or
predetermined knowledge. Learning, in this context, is the process of remem-
bering information, adapting the information to solve a problem, and general-
izing that knowledge to an unseen circumstance. Humans are capable of doing
this process all the time. Find a picture and description of important charac-
teristics of an animal, and a person might be able to recognize the animal if
they encounter it later. Alternatively, people learn how to distinguish people
they know from others they do not. For a computer, on the other hand, finding
a way to replicate this process can be quite difficult given that one has to de-
fine how to modify and adapt to new knowledge. Many different methods have
been proposed to simulate this process of learning based on data, ranging from
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something as simple as finding the line of best fit, linear regression, for a given
number of sample points, to complex convolution neural networks performing
image segmentation. Some models are iterative, learning by repetition on the
data, while others not. Additionally, a number of different training schemes
are used in conjunction with different methods, leading to a large possibility of
available options.
This following subsection will detail a number of key concept related to ma-
chine learning. Firstly the basics of handling datasets and then the concept of
different types of machine learning. Next the key concept of Overfitting/Under-
fitting and its relation to the Bias-Variance Tradeoff will be explained. Given
the importance of reducing bias and variance, the two following sections will
detail two possible ways of achieving that, namely Regularization and Cross-
Validation, respectively. Section 2.3.6 outlines a method to search over a large
hyperparameter space for methods that have hyperparameters that impact the
models performance. Lastly, quite pertinent to the dataset that is used in this
thesis, the concept of Curse of Dimensionality and Feature Engineering is intro-
duced in section 2.3.7 and 2.3.8, respectively.
2.3.1 Process of Learning
The process of learning from data mentioned above consists of a number of key
elements, and may be summarised as follows; ”A computer program is said to
learn from experience E with respect to some class of tasks T and performance
measure P, if its performance at tasks in T, as measured by P, improves with
experience E”, chapter 5 [18]. The experience E, is a set of data samples xi
consisting of a k features xi = (xi,1, ..., xi,j). The exact shape of the feature
space need not be, as outlined above, a single vector. For instance. an image
has a three dimensional feature space consisting of a pixel width, pixel height,
and color depth. Alternatively, a single sample could be the string of a sentence
instead of a dedicated feature space, however, in language based models, a
preprocessing step includes converting a sentence to a set of features. For the
purpose of this thesis the feature space will be considered as a one dimensional
space of k features. In cases where a feature is categorical, the feature will be
converted to a set of binary features through a one hot encoding, thus each
feature will be treated as a real number.
The data that is used is generally split into three components, the training,
test, and validation sets, respectively. Each dataset serves a specific role in the
learning process. Firstly, the machine has to learn from something, and this is
the training set. To know that a model has learned something, and can apply it
to unknown samples, we use a test set, checking the strength of the generaliza-
tion of the model. However, a simple split between training and testing need be
sufficient for all use cases, hence the introduction of the validation set. Consider
a model like K-Nearest-Neighbours that has a parameter k, the number of clos-
est points to a point xi is used to determine the classification of xi. The model
output can drastically change depending on what value of k is selected, hence
a validation set will be used to determine the most optimal selection of k. It is
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important to note that the validation set is separate from the test set, as the
validation set’s primary role is to determine the relative performance of different
choices for a model or iterative steps as a model trains. For instance for a neural
network, after each epoch, it validates the current trained model on a validation
set to determine how well it has generalized so far. A common approach for
validating during training, or for selecting different parameter choices, will be
detailed in section 2.3.5.
The task T can vary wildly. Broadly speaking it can be categorised into
Supervised, Unsupervised, and Semi Supervised/Reinforcement learning. For
supervised learning each data sample has an associated target value yi such
that each element in X is of the form (xi, yi). The target/response/class deter-
mine the associated class or value of a specific sample, and the learning process
aims to learn to predict the target of new data samples. In the case of a categor-
ical target the problem is classification, while for continuous variables it would
be a regression problem. Other types of problems, like image segmentation
have a different response, however, for the purpose of this thesis, classification
and regression is the important sub-tasks for supervised learning. Unsupervised
learning, on the other hand, has no target, hence the models aim to learn some
underlying structure in the data. For instance, clustering of data samples that
are similar or learning some lower dimensional representation of the data. Meth-
ods of dimension reduction will be mentioned in more details in section 2.3.8.
Semi-supervised learning is a hybrid approach between supervised and unsuper-
vised learning. In cases where recording data samples is cheap, but recording
targets is expensive, models can be trained on a smaller set of labeled data in a
supervised way, then trained on a larger unlabeled dataset in an unsupervised
way. Alternatively a model could consist of multiple smaller models that act in
conjunction to learn on unlabeled data in a teacher-tutor relationship or only
know that its prediction is wrong, but not what the correct prediction is, usu-
ally referred to as learning by critic. Given the nature of the problem for this
thesis, only supervised learning will be discussed, with some minor mentions of
unsupervised learning as a means to visualize data in lower dimensions.
The performance measure, P, will be explored in more detail in the following
section.
2.3.2 Performance Measure P
A measure P is necessary to determine if a model has learned. The measure
used depend on the type of task being evaluated, but is generally a dissimilarity
measure.
For regression models the Mean Square Error (MSE) is normally used, chap-
ter 2.2 [25], which is simply
∑n
i=1(yi − f̂(xi))2 for some model function f̂ esti-
mating an underlying true distribution f . However, the choice of MSE is not
arbitrary. To see this consider the principle of maximum likelihood. For an
arbitrary probability distribution P (X|θ) the maximum likelihood is the choice
of θ such that θML = arg maxθ P (X|θ). For certain probability distributions







Now consider the case of a linear regression model. Let f̂(x; θ) be the re-
gression model where θ is the set of learned polynomial coefficients including a
bias term. Given that the goal of the model is to predict a response y based on
f , instead the correct formulation is the maximum likelihood of the conditional
probability distribution arg maxθ `(θ) = arg maxθ P (Y |X; θ, b). Assume that
the noise of the data is Gaussian with mean zero, i.e. each sample response y is
of the form y = f(x) + ε for ε N (0, σ2). Given a linear case the log likelihood




logN (yi − θTxi |0, σ2),











(yi − θTxi)2, (1)
where the last term is equivalent to the sum of squared difference between the
target and the predicted target, see chapter 5.5 [18]. The maximum likelihood
solution to a regression problem could be solved analytically from (1), however,
more complex models would be more difficult, or impossible, to solve analyt-
ically. Additionally, it is entirely possible that the noise in the data is not
Gaussian, hence the log likelihood would be different.
The maximum likelihood approach comes naturally if we consider the Kullback-
Leibler divergence;
DKL(p || q) =Hp(q)−H(p),
=Ex p[log p(x)− log q(x)], (2)
of two distributions q and p, with x sampled from q, chapter 5.5 [18]. Hp(q)
is the cross entropy between p and q and H(p) the entropy of p. If p is the
underlying data generating distribution and q is the model distribution, then























Thus using maximum likelihood estimate for a model distribution is an at-
tempt at making the model distribution and the data distribution as similar
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as possible. This approach would be ideal if we could have access to the data
generating distribution, however, that is the distribution pmodel is attempting to
estimate. Instead we will only be able to make the model distribution as close
to the distribution of the available data as possible, however, it still remains a
good approximation. Many machine learning methods will use KL-divergence
indirectly due to other cost functions, or directly.
One approach to classification is to perform regression and base the pre-
dicted response based on f̂(x) = wTx. A simple rule could be to classify all
samples above 0 as class 1 and all samples below 0 as class 0 in a binary classi-
fication problem, however, this hard classification boundary might not be ideal
given the uncertainty near the boundary. This is the principle approach for
the Support Vector Machine algorithm which will be explained in section 2.5.1.
Alternatively the regression response could be transformed via a function such
that the decision boundary becomes smooth. A standard function for this kind
of problem is the sigmoid function σ(x) = 11+exp (−x) . With this function the
probability of a sample being classified as class 1 is P (y = 1 | x) = σ(wTx),
chapter 4.3 [25]. It can be shown that the maximum likelihood estimate for the
weights w is the binary cross entropy, that is;
``(X, θ) = log
n∏
i=1










which is the binary cross entropy of a Bernoulli distribution.
However, the performance measure P need not be directly linked to the un-
derlying cost function that defines the optimal learning procedure. For instance
accuracy is a simple measure of how many samples are predicted correctly. Sim-
ply it is the expectation of the function I(yi, ŷi) that has a value 1 when yi = ŷi
and zero otherwise. Or in simpler terms, the number of correctly predicted
samples divided by the total number of samples. Models that have a higher
prediction accuracy perform better at classification in theory, however, the ac-
curacy measure might be misleading. To see why, consider a dataset with a class
imbalance where 90% of the samples are of class 1 while the remaining 10% are
of class 0. In this case a model that always predicts all samples to be 1 would
get a 90% accuracy score, yet it has clearly not learned anything meaningful in
separating the two classes. An alternative approach to measuring accuracy is












for a binary classification problem where TP, FN, TN, and FP are related to
the concept of a confusion matrix, seen in table 1. This performance measure
penalizes models that get good accuracy based on the class imbalance, giving
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Prediction: False Prediction: True
Label: False True Negative False Positive
Label: True False Negative True Positive
Table 1: The columns are the predicted class and the rows are the true labels y.
Each cell records the number of samples with the ordered pair of labels (y, ŷ).
Each cell in this example of two classes have a name. True Negative (TN) is the
number of samples that are correctly predicted as false. True Positive (TP) is
the number of samples that is correctly predicted as true. Both False Negatives
(FN) and False Positives (FP) are the cases where the prediction is different
from the true label.
them a balanced accuracy of 50% in a binary classification problem, or specifi-
cally 1c where c is the number of classes. The strength of a models performance
is how far it deviates from the baseline of 50%, which will be discussed in section
4.
However, in the class imbalance case above, we could instead measure how
much it predicts class 0 as 1 and class 1 as 0. This can be shown in a confusion
matrix [16]. A confusion matrix is an C × C matrix for number of classes C,
where each row is the true class and each column is the predicted class. Each
cell is the number of occurrences of the pair (yi = ca, ŷi = cb) for some classes
ca and cb. The accuracy measure mentioned above is simply the diagonal sum
divided by the total number of samples when viewed as a confusion matrix.
Consider a two class problem confusion matrix shown in table 1. One way
to include the rate of incorrect predictions in a scoring metric is using a Re-
ceiver Operating Characteristic (ROC) curve [16]. An ROC curve plots the
False Positive Rate (FPR) against the True Positive Rate (TPR), calculated by
FPR = FPTN+FP and TPR =
TP
FN+TP . Note that inherent in the computation
of the TPR and FPR, the algorithm adjusts the threshold of the probability of
a true sample. For instance, in the logistic regression example a probability of
P (yi = 1 | x) > 0.5 is classified as 1, however, this does not have to be the op-
timal choice of a threshold for a given model. In this way, the ROC curve finds
the most optimal threshold, and from that threshold, computes the TPR and
FPR. The final curve should be above the diagonal curve from (0, 0) to (1, 1),
also called the line of chance, with a better model being closer to the top left
corner. Models that fall below the line of chance need not be worthless, consid-
ering such models are simply predicting true samples as false and false samples
as true. Switching the prediction output will yield a model that is above the
line of chance. A measure of a ROC curve is the Area Under the Curve, which
is simply the integral of the ROC curve [16]. Thus the worst possible AUC is
0.5, given that all curves with AUC less than 0.5 can be switched to above 0.5
with the trick mentioned above.
For the purpose of this thesis, the imbalanced accuracy measure and AUC
will be used as performance measures.
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2.3.3 Bias-Variance Tradeoff
Consider a simple regression problem where the variable y is dependent on x
via an unknown functional relationship y = f(x) + ε where ε some noise with
mean 0 and variance σ2. Without loss of generality the mean of the noise can
be assumed to be 0, for if it was not, it could be considered as a constant term
in the function f . As described in section 2.3.2 the normal loss function for
regression is MSE. Consider the expected error of any given point x outside the
training set for some function f̂ trained on D, that is ED[(y − f̂(x;D))2]. This
decomposes into three terms called the bias, variance, and irreducible error,
three key concepts when analysing a models performance. The derivation of the
exact relationship is detailed below.
For the purpose of notation, the expectation outlined below will be assumed
to be over the domain D of the training set unless specified otherwise. the
functions f(x;D) and f̂(x;D) will be abbreviated as f and f̂ to simplify the
notation. Thus by the definition of expectation we can write;
E[(y − f̂)2] =E[(f + ε− f̂ + E[f̂ ]− E[f̂ ])2].
Expand and apply linearity
=E[(f − E[f̂ ])2] + E[ε2] + 2E[ε(f − E[f̂ ])] + E[(E[f̂ ]− f̂)2]
+ 2E[ε(E[f̂ ]− f̂)] + 2E[(f − E[f̂ ])(E[f̂ ]− f̂)],
Given that f and E[f̂ ] are deterministic, that is they are independent of the do-
main of expectation D, the expectation of a product is the product of expecta-
tions. Additionally, since ε is independent of all other variables, its expectation
can be multiplied out by the product rule, that is if X and Y are indepen-
dent random variables, then E[XY ] = E[X]E[Y ]. Hence the above expression
simplifies to;
=(f − E[f̂ ])2 + E[ε2] + 2E[ε]E[(f − E[f̂ ])] + (E[f̂ ]− f̂)2
+ 2E[ε]E[(E[f̂ ]− f̂)] + 2(f − E[f̂ ])E[(E[f̂ ]− f̂)],
furthermore, given that ε has a mean of zero, its expectation is by definition
zero, cancelling out the epsilon expectation terms. The last term cancels given
that by linearity, E[E[f̂ ] − f̂ ] = E[E[f̂ ]] − E[f̂ ], which is simply zero given that
the expectation of an expectation is the expectation, i.e. E[E[f̂ ]] = E[f̂ ]. Thus,
=(f − E[f̂ ])2 + E[ε2] + (E[f̂ ]− f̂)2,
=Bias[f̂ ] + Var[ε] + Var[f̂ ], (5)
which is the outcome outlined above. The simplification from the last line comes
from the definition of variance, which by simple expansion and application of
linearity shows that, Var[X] = E[X2] − (E[X])2 for some random variable X.
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Similarly for the ε term, since E[ε] = 0, then Var[ε] = E[ε2] − (E[ε])2 = E[ε2].
This relationship between the variance and bias of the model to the error is key
to understanding how to create a model of best fit for a given dataset. The
variance of the error, however, is the underlying error that comes from some
unknown influence on the variable y. For instance, it could be due to a number
of missing variables that would adequately explain the relationship, or simply
that the underlying mechanism has some inherent unpredictability. Regardless
of its source, it serves as a lower boundary for the mean square error on any
dataset, thus the loss of the cost function will never get to zero.
The variance represents the error related to the subsampling of data that
is done for the training set D compared to the true distribution. Thus smaller
datasets tend to suffer heavily from variance and increases the dataset size re-
duces the impact of variance. The bias is the error from the inherent assumption
built into the model for the function f̂ . More complicated models tend to re-
duce bias while simple models increase the bias. For instance a model like linear
regression has a low complexity, thus high bias, from the limited number of dis-
tributions it can fit. On the other hand polynomial regression will have a higher
degree of complexity and infer less bias.
Figure 1: Shows the difference in line of best fit for polynomial regression on
the function f(x) = sin(1.5πx) +N (0, 0.2) for x ∈ [0, 1]
This example can be seen in figure 1. The figure shows the true distribution
f(x) = sin(1.5πx), the 42 samples from said distribution with an added noise
term of N (0, 0.2), and the polynomial regression. The figure on the left shows
a first degree regression model, right shows a 15th degree regression model, and
the middle shows the degree that minimizes the mean square cross validation
error between 1 and 15. The linear regression model cannot hope to fully capture
the variability in the true distribution given its low model complexity, leading to
a high bias term. The 15th degree regression model suffers from high variance
and is clearly a poor fit given the right tail end of the regression line. The clearly
poor fit of both the 1st and 15th degree polynomial regressions are examples
of underfitting and overfitting, respectively, chapter 5.2 [18]. The connection
between overfitting/underfitting and model complexity is shown in figure 2.
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Figure 2: Shows a sample training and test error plotted against model complex-
ity. Models that are the the left of the optimal minimum test error is considered
underfitted, while models to the right of that line is considered overfitted.
2.3.4 Regularization
Models can have a high complexity leading to fitting to the underlying noise
of the data, as described in the section above 2.3.3. One way to remedy this
overfitting is to use a regularization method that constrains the possible model
complexity. Consider a polynomial regression model with degree k using mean
square error as the cost function. Let each coefficient be βj . This regression
model will then be used to estimate some polynomial function, f , of degree less
than k. In this case the model that is used has too high model complexity and
will overfit to the underlying noise, especially so with few samples. However, if
the model could just zero out specific coefficients, it could express polynomials
of lower degrees without the possibility of having too high model complexity.
One approach could be to force the coefficients βi as close to zero, thus if a par-
ticular power is not necessary to estimate the underlying polynomial function,
the coefficient will be set to zero. This is the l2-norm, or in terms of polyno-
mial regression, a ridge regression model, chapter 6.2 [25]. Mathematically, the












β2j ≤ s, (6)




j term to the cost function. This
means that the model is penalized for having high coefficient magnitudes, and
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thus irrelevant coefficients will tend to zero. l2-norm forces coefficients close
to zero, however, not exactly to zero. In certain situations, like when doing
Feature Engineering, as discussed in section 2.3.8, forcing the algorithm to set
coefficients equal to zero can be beneficial. One way to achieve this is using the
l1-norm instead, that is add a λ
∑n
j=1
∣∣βj∣∣ term to the cost function. This is












∣∣βj∣∣ ≤ s. (7)
In terms of regression, this is called a LASSO regression model, chapter 6.2
[25]. The reason the coefficients are forced to zero, compared to a Ridge model,
comes from how the restriction of the coefficient space intersects with the level
sets of the cost function. An example of this is shown in figure 3 where the
red concentric circles are level sets of a cost function, green circle is the l2-
norm restriction, blue diamond is the l1-norm restriction, and the axis are two
coefficients β1 and β2 for some model with two coefficients. The intersection
between the level set of a cost function and the restriction function on the
coefficient space is the solution model. Given this, the shape of a l2-norm has
a higher chance to intersect with the level set away from the axis compared
to an l1-norm. However, one could use a hybrid approach between these two
restrictions, i.e. a linear combination of the two, which leads to what is called








mixing coefficient λ1, λ2. The visual representation of elastic-net regularization





Figure 3: The figure shows a simplified picture of the intersection of the level
sets of a cost function, red concentric circles, with l1 (blue) and l2-norm (green)
restriction on the coefficient space in two dimensions. Each axis represents one
coefficient, i.e. β1 and β2. Each red circle represents a boundary of equal loss,
i.e. a level set of the cost function, and circles are used as a simplification, given
that the level set can be a much more complex boundary. The intersection
between a red circle and either the green or blue shape represents the solution
a model finds. Take the l2-norm, the second most outer level set intersects with
the green circle, forcing the coefficients to be small, yet not zero. For l1-norm,
the intersection instead occurs at an axis intercept. In general the intersection
for l1 would occur at the axis intercept, which forces coefficients to zero.
The three types of regularization mentioned above are examples of weight
decay regularization and can be used for more complicated models than poly-
nomial regression. Support Vector Machine, as is discussed in section 2.5.1, is
one prominent example that is relevant to this thesis, however, it could also be
applied to individual layers of a neural or convolutions neural network, chapter
7.1 [18]. However, regularization is a more general principle than simply weight
decay. Regularization is any modification we make to a learning algorithm that
is intended to reduce its generalization error but not its training error, chapter
5.2 of [18]. With this in mind a number of different methods can be considered
regularization beyond just weight decay. For instance, early stopping of itera-
tive algorithms, i.e. neural networks and stochastic gradient descent classifier,
parameter sharing, i.e. convolutions network architecture, or bagging/ensemble
methods, one of which will be described in section 2.5.5.
2.3.5 Cross Validation
Consider a specific split of data into a training, testing, and validation set.
During training the model will fit to the underlying distribution, or eventually
the noise with enough model complexity, however, a similar problem can be seen
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with the validation set. If the validation set is used to determine the optimal
hyperparameter choices, then it stands to reason that the choice of parameters
is inherently dependent on the selection of the validation set. Since the set is
predetermined randomly before the training process, the model will suffer from
the variability in said selection, when selecting hyperparameters. Additionally,
as detailed in 2.3.3, getting more data reduces the variance, which means that
if there is already little available data, or the validation set is selected to be
sufficiently large, unstable models would suffer from the reduced number of
training samples.
A solution to minimize the impact of the variability from selection of the
validation set is using a training method called cross validation, chapter 5.1
[25]. Consider figure 4, the entire dataset is split into training and testing in
step A). Then in step B), during training, the dataset is split into five equally
large portions and the model is trained five separate times. The selection of five
is completely arbitrary, and is purely done as an illustrative example. In each
training iteration, the validation data consists of one of the five components,
different each time, and the training set is the rest of the samples. Similarly to
how a model can incur variance from the choice of the validation set, each of
the individual models that are trained can as well, however, since five models
are trained, we can average their contributions and determine an average score
for a particular model.
Figure 4: In step A) the whole dataset is separated into a test and training
set, and in step B) cross validation is used to train a model. The training set
is separated into k number of folds, in the image k = 5. Then the model is
trained k times on different combinations of the folds with one fold held out for
validation of said trained model.
A special case of the k-fold cross validation (k-CV) is leave one out (LOO)
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cross validation, chapter 5.1 [25]. For LOO the choice of k is equal to the
number of training samples, hence the training set consists of all n− 1 samples
and only a single sample is used for validation. The contribution of each model
is combined to get an average performance, similarly to k-CV. LOO has the
consequence of requiring a lot more computation, leading to it being unfeasible
to use.
The two methods have an impact on the variance and bias of a model. In
chapter 5.1 of An Introduction to Statistical Learning [25] it details that k-CV
improve the variance over a simple predetermined split, or more specifically
compared to a 50-50 split of the dataset into training and validation. Certainly
in this case, the reduction in training samples have an impact on the inherent
variance of the data that the model learns from. Comparing LOO and k-CV, the
former is close to an unbiased estimate of the whole training set, given that the
training set in each iteration of LOO consists of almost the entire training set, i.e.
n− 1 samples. Comparatively, k-CV contains a smaller proportion of the total
training set for when k < n, leading to a more biased estimation of the total
training set, however, still smaller than the bias inherent in a predetermined
random split. When it comes to variance, they argue that the reduction in
bias from using LOO over k-CV comes at the cost of increased variance. The
increase in variance stems from the high positive correlation between the n
trained models given the relatively small change removing one sample will have
on the trained model. Furthermore, the mean of many highly correlated values
have a high correlation, thus an increase in the variance of the model. k-CV
still suffers from the positive correlation between models, however, to a lesser
extent, thus incurring less variance.
That being said, other researches have a different view on the difference
between LOO and k-CV. For instance [53] argues that simply stating that LOO
suffers from more variance than k-CV is not entirely correct, given that it is
dependent on the context of the use of cross validation. The paper details a
number of experiments done for LOO, k-CV, and k-deletion cross validation,
and shows that the increase in variance for LOO over the other methods occurs
for models like LASSO (l1 weight decay loss for regression model) and SCAD (a
non convex weight decay loss), see [14] for specifics of the SCAD loss function.
This is due to the uncertainty incurred from small penalty coefficients and large
feature space.
For the purpose of this thesis, cross validation will be used to select hyper-
parameters and to select between possible models, see section 3.6 for the specific
hyperparameters spaces for the models that was used.
2.3.6 Randomized Grid Search over Hyperparameter Space
For models like KNN and polynomial regression a single hyperparameter needs
to be selected, number of neighbours and degree of the regression, respectively,
to use the algorithms. One approach would be to train a model for each pos-
sible choice within some reasonable set domain and select the best performing,
according to some predefined metric, choice. This approach remains simple
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enough when a model only has one possible parameter. However, for models
with considerably more possible options can be quite resource intensive. An al-
ternative approach is to do a randomized grid search over possible combinations
of hyperparameters.
That is for some hyperparameter space H = S1 × S2 × ... × Sk consisting
of sets Si of some number of categorical options or continuous options, each
iteration of the randomized search would select an element h ∈ H where h =
(S1,i1 , S2,i2 , ..., Sk,ik) a vector of elements of each of the parameter spaces Si. A
model is trained, through the process of cross validation, and scored according
to a predefined metric. The combination of parameters that perform the best
is selected, or alternatively some specific parameter options can be eliminated
and a more refined search can be performed again.
A randomized grid search allows for more complex hyperparameter spaces
for models to be explored, and estimated, at a reduced computational cost.
Additionally, even if a single model only has a single parameter to determine,
the model could be used in conjunction with other models as a pipeline, leading
to the total hyperparameter space being considerably higher. As detailed in
section 3, the use of feature selectors and dimension reduction methods can
be added, and explored, in a randomized grid search over the hyperparameter
space.
2.3.7 The Curse of Dimensionality
One problem of particular importance to this thesis is high dimensional data,
that is the feature space is larger than the sample space. High dimensional data
posses a number of problems related to machine learning, the first of which is
the locally sparse neighbours around each sample. Consider a point p in some
metric space, then the epsilon neighbourhood of point p is the set Bε(p) such
that Bε(p) = {x ∈ X | d(p, x) < ε} for some metric d where X is the sample
space. Given the space ordinarily used in machine learning is a euclidean space,
the metric will be the euclidean metric d(p, x) = |p−x| unless otherwise stated.
As the dimensionality increases, the volume of the epsilon ball shrinks, past
a certain point. To see this, consider the function of the volume of a unit
hypersphere as the dimensionality increases. This is shown in figure 5. The
formula for the volume of a hypersphere is Vn =
2π
n Vn−2, thus when n > 2π
the volume decreases, as shown in the figure. This reduction in volume means
the local neighbourhood gets more and more sparse as points get further and
further apart, given that the volume of space the sphere encompasses decreases.
An alternative way of presenting this problem, courtesy of chapter 5.11 of
[18], is to consider a categorization of each feature into ten unique values. When
the number of features is only one, the total number of samples needed to have
at least one sample of each unique value is quite small. When the dimensionality
increases, the number of samples necessary to fully express all possible combi-
nations increases exponentially with the dimension. In two dimensions there
would need to be at least 100 samples, but in just six dimensions there would
need to be at least one million samples. However, each unique combination
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Figure 5: The figure shows the volume of a unit n-sphere against the number of
dimensions. As the number of dimensions increases, the volume rises to a peak
and then falls, tending to zero as n −→∞. Mathematically the volume of a unit
n-sphere is Vn =
2π
n Vn−2 in relation to the volume of an (n-2)-sphere, thus the
volume would decrease when n > 2π.
need not be relevant, however, without having a sufficient number of samples,
a model would have no knowledge on whether the combinations it does have is
sufficient or not.
The underlying problem is that distance metrics become less useful with
more dimensions. Consider a set of independent and identically distributed data
samples X = {x1, ...xn} and a random reference point Q, then as the dimen-





DMAXk ≤ (1 + ε)DMINk
)
, (8)
where DMINk = min{dk(x,Q) ∀ x ∈ X}, DMAXk = max{dk(x,Q) ∀ x ∈
X}, and epsilon is some arbitrary positive number ε > 0, see [4]. This means
that models that rely on a distance metric, or nearest neighbours, break down
in higher dimensions under the assumption of the data being independent and
identically distributed.
Given the nature of the data that is used in this thesis, as described in
section 3.1, properly mitigating the difficulties posed by higher dimensional data
is crucial. The next section will detail a way to mitigate the high dimensionality
in the form of Feature Engineering.
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2.3.8 Feature Engineering
Data that is considered high dimensional, i.e. m > n where m is the number
of features and n the number of samples, suffer from breakdown in the distance
metric and local neighbourhood sparsity. Feature Engineering is one way to
mitigate these problems by reducing the dimensionality of the data from m to
some lower dimensional space m̂ < m, and usually m̂ < n by some function
φ : Rm −→ Rm′ . There are two principle ways of reducing the dimensionality,
the first is selecting a subset of features that is deemed most relevant for the
given task or possess some important characteristic, or perform a linear, or non-
linear, transformation of the feature space and embed it in a lower dimensional
space. The latter being called dimension reduction or representation learning
and the former being subset selection.
Dimension reduction methods involve some linear or non-linear transforma-
tion of the feature space to a lower dimensional space. A simple example of
such a method is Principle Component Analysis (PCA), chapter 10.2 [25]. PCA
creates a set of orthogonal basis vectors of the covariance matrix for the data
samples. A subset of those basis vectors can be selected to perform dimension
reduction. The selected basis vectors are based on the eigenvalues for those
orthogonal basis vectors. Other more complex methods exists with different
desirable properties. For instance, Universal Manifold Approximation (UMAP)
uses a local distance metric between nearby points to find a lower dimensional
embedding [37]. Dimension reduction methods serve an important role in fea-
ture engineering when the features are deemed important, however, if a feature
is simple noise, then the noise will be included in the lower dimensional repre-
sentation. Furthermore, to classify any new samples the whole original feature
space is needed, something that might not be a desirable property. However,
methods such as PCA and UMAP are good visualization tools for high dimen-
sional data in two dimensions.
The form of feature engineering that will be used in this thesis is feature
selection. There are a number of different ways to performing feature selection,
but principally there are two approaches that will be used, filter methods and
wrapper methods. A filter method is a simple statistical approach ranks each
feature for its importance. In general, these methods are univariate approaches
for determining relevant features. This means that filter methods tend to select
variables that are highly correlated. Certain methods have been developed to
counteract such behaviour, like Fast Correlation Based Filter (FCBF), however,
they are outside of the scope of this thesis [51]. The types of filter methods
used are described in more detail in section 2.4. Wrapper methods consist
of training a classifier model on the data and using metrics on said model to
determine relevant features, chapter 6.2 [25]. The simplest approach is applying
l1 weight decay to a classifier and using the variable coefficients as a measure of
a feature’s importance. Other methods, like Random Forest [6], inherently rate
each feature as part of the learning process, hence that can be used instead.
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2.4 Filter Methods
Four types of filter methods will be used as part of this study, those being
One-way Analysis of Variance (ANOVA), Fisher Score, ReliefF, and Mutual
Information. Each of the methods will briefly be explained below.
ANOVA computes the F-statistic F = (TSS−RSS)/pRSS(n−p−1) where n is the number
of samples, RSS is the sum of residual squares, TSS is the sum of total squares,
and p is the number of relevant features for testing the null hypothesis β0 =
β1 = ... = βp = 0 of a regression model, see [25] chapter3.2. Given that the
analysis is univarate, p = 1. ANOVA does require that the scale of each of the
features are the same, which is guaranteed by the standardization done in the
preprocessing step.
The Fisher score selects features such that distance to other classes is as
large as possible and within class distance is small [19]. Specifically the Fisher





where Xj is the feature vector of feature j,
c is the total number of classes, nk is the number of samples with class k, µj,k is
the mean of the j-th feature vector for samples with class k, and µj is the mean
of feature vector j.
ReliefF is an extension of the Relief algorithm that iteratively updates each
features importance based on the closest within class samples and closest dif-
ferent class samples to the given sample [48]. Specifically it selects a random
sample Ri in step i, then finds the k nearest neighbours with the same class Hj
and k nearest with a different class Mj , called nearest hits and misses, respec-




















where diff(A, I1, I2) is a function defined on samples I1 and I2 that is 0 if the
values of feature A are equal for the two samples, otherwise it is 1. The algorithm
has an extension to missing values, however, that is not important for this thesis.
Lastly Mutual Information is the Kullback-Liebler divergence between the
join probability distribution of two random varaibles with the product of said










for discrete variables, or in terms of entropy I(X,Y ) = H(X)+H(Y )−H(X,Y ).
Further details on mutual information can be found in [29].
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2.5 Classification Models
The following sections will detail different classifiers are used as either feature
selectors and/or classification, see section 3.
2.5.1 Support Vector Machine
Support Vector Machine (SVM) is a popular supervised learning method that
aims to select a decision hyperplane that separates a binary classification prob-
lem. The hard margin version was introduced in a paper in 1992 [5] and the
soft margin version was presented three years later in [8]. The hard margin





. However, there are many such hyperplanes provided the
data is linearly separable, in the case it is not linearly separable the soft margin
approach needs to be used. SVM specifically selects the hyperplane such that
the margin is maximized. The margin is the distance between the hyperplane
and the parallel lines at the closest point of each class. Maximizing the distance
is equivalent to minimizing 12 ||w||
2 subject to yi(w
Txi + b) ≥ 1 ∀i = 1, ..., n,
also known as the primal formulation of SVM. The data points that lie on, and
inside, the margin boundary are called the support vectors and fully define the
decision boundary.
The above formulation is the hard margin approach, however, given that
data is not linearly separable in general, the following derivation will detail the
soft margin approach. Instead introduce a slack variable ξi ≥ 0 for each data
sample that is the amount of miss-classification by the separating hyperplane,
which is equal to 0 in cases where data points are not misclassified. The primal









Txi + b) ≥ 1− ξi, (9)
where C is a hyperparameter that determines the degree to which samples a
penalized for being misclassified. Large C converges to a hard margin. The
minimization problem can be solved by Lagrangian optimization. Consider a
set of constraint parameters αi such that 0 ≤ αi ≤ C, then the Lagrangian is;












Txi + b)− (1− ξi)
)
, (10)














αiyi = 0, (11)
called the dual formulation. The dual formulation can be solved in terms of α




The formulation of the model so far is linear. One way to add non linear
approximation to the model is to add a non linear feature functions φ : Rm −→
Rm′ from the feature space m to some larger feature space m′. Consider a new
data sample x and some feature function φ(x). The weights are defined as w =∑n





main computational cost of the non linear transformation φ will be computing
the inner product φ(x)Tφ(x). However, with a specific choice of φ, the inner
product can be defined as a function in the original feature space of size m,
hence forgoing computing in the feature space of size m′. Any such choice of φ
will lead to a kernel function K(x, x′) = φ(x)Tφ(x′) and the decision function






. The kernels that will be
relevant for this thesis are the Polynomial, Radial Basis Function (RBF), and
Sigmoid kernels, each defined below:
Polynomial: K(X,Y ) = (γXTY + r)d,
RBF: K(X,Y ) = exp(−γ||X − Y ||2),
Sigmoid: K(X,Y ) = tanh(γXTY + r),
for some hyperparameters γ, r, and d.
2.5.2 Logistic Regression
Logistic Regression was briefly introduced in section 2.3.2. For any given sample
x, logistic regression assigns a probability P (y = 1|x) = σ(wTx + b). The
decision boundary is P (y = 1|x) > 0.5, or simply the decision hyperplane
wTx+ b = 0. The optimal choice of weights w is the maximum log likelihood,
see equation 3. The exact method of optimization for logistic varies. For the
purposes of the implementation used in this thesis, liblinear [15] and lbfgs [33]
solvers are used, as detailed in the Sci-kit learn documentation, see software
section 3.2, for logistic regression. The elastic-net logistic regression model is
optimized by stochastic gradient descent instead of liblinear or lbfgs.
2.5.3 Stochastic Gradient Descent With Modified Huber Loss
It is a bit of a misnomer to have Stochastic Gradient Descent (SGD) as a classi-
fier, given that SGD is an optimization algorithm, however, the references to a
SGD classifier in this thesis is specifically SGD used to optimize Modified Huber







λR(w) where R(w) is the weight decay regularization and L(yi, f(xi)) is the
modified Huber loss function;
L(yi, f(xi)) =
{
max(0, 1− yif(xi))2 yif(xi) > 1
−4yif(xi) otherwise
(12)
where f(x) = wTx + b. This loss function is less sensitive to outliers than
ordinary least square loss. This is but one of many options for loss functions,
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however, given linear SVM and logistic regression is used as part of the feature
selection to begin with, only modified Huber loss will be used.
The process of optimization of SGD involves iteratively updating the weight
parameters by the gradient of the weights until it reaches a convergence or a
maximum number of iterations. Specifically the t-th iteration, the weight update
rule would be;











for some learning rate γ. The choice of γ is selected as ”optimal” in the Sci-kit
learn package, which equates to γt =
1
α(t0+t)
at time step t and a heuristic pa-
rameter t0. This is an example of a decaying learning rate, that is the proportion
of change is reduced as learning progresses.
2.5.4 Decision Tree
A Decision Tree is a non-parametric model that can be used for classification or
regression, however, for this thesis I focus on classification. The model consists
of a set of simple decision rules based on features of the data, starting at the
root and ending at leaf nodes. At each node a single feature is selected, based on
an information metric, and a specific split is selected to determine the decision
function for its two children nodes. The process of building new nodes continues
until it reaches a specified maximum depth or all samples at a given node consists
of a single class, hence the node will be a leaf node. This means that the tree
representation of a Decision Tree need not be balanced. The type of information
measure used to select a feature is a set parameter, either Entropy H(Z) =
−
∑
c pc + log pc and Gini Index G(Z) =
∑
c pc(1− pc) for some subset Z of the
dataset X and proportion of presence, also refereed to as the class probability,
pc for class x.
Note that Decision Trees tend to overfit heavily when the data is high di-
mensional, and its use for feature selection is simply to see the possible features
it would use, more so than an assumption that the model could select very good
predictive features.
2.5.5 Random Forest
Random Forest is an ensemble method that trains many smaller estimators and
combines their predictions to make one final prediction for each sample [6]. Each
estimator is a small decision tree estimator that gets a random subset of the
available features to consider, thus reducing the bias the model can have for any
given feature.
Given the nature of Random Forest classifier, it will naturally select a lot
of relevant features, even when few features are the only relevant ones. This
means that feature selection on the basis of a Random Forest model selects
very many features at relatively similar feature importance. Furthermore, the
feature importance tends to favour features that have many unique values.
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2.5.6 K-Nearest Neighbours
K-Nearest Neighbours (KNN) is a simple classification algorithm that predicts
a class c for a point pi where c is the majority class in the k closest points to
pi based on a given distance metric, chapter 7.2 [36]. KNN is an example of
a non parametric model that can fit unrealistic decision boundaries for a low
number k. In addition to selecting k, the model is also dependent on the choice
of distance metric. For the purposes of this thesis the distance metric will be
Minkowski distance of degree s, either 1, 2, or 3. Minkowski distance is defined




. Euclidean is a special case when s = 2.
2.5.7 Gaussian Naive Bayes Classifier
The Naive Bayes classifier [41] is built on the relationship between the pos-
terior and likelihood with an assumption of conditional feature independence.
Consider a Bayesian inference problem;
P (θ | D) = P (D | θ)P (θ)
P (D)
,
for some model parameters θ and data D. The term P (θ | D) is the posterior
probability of parameter θ given the input data, P (D | θ) is the likelihood of
the data given the model parameter, and P (θ) is the prior probability of the
model parameters before observing any data. For classification the goal is to
predict class yi based on the data samples xi,1, ..., xi,m. Consider a single data
sample labeled E and the predicted class of said data sample y for simplicity.
The features of E are then x1, ...xd.
The conditional feature independence assumption means that it is assumed
that the features are independent of each given the class;
P (xj | y, x1, ..., xj−1, xj+1, ..., xm) = P (xj | C),
that is the likelihood can be simplified as the following product via marginal-
ization P (x1, ..., xm | y) =
∏n
j=1 P (xj | y). Given this simplification, the Naive
Bayes classifier assigns class y to a sample E that has the highest posterior
probability;





P (xj | y).
The choice of using the naive assumption leads to poorly calibrated proba-
bilities, however, the predicted class, based on the maximum posterior, is often
correct.
The specific type of model used in this thesis is the Gaussian Naive Bayes
classifier, where it is assumed that the likelihood probability is Gaussian. That





The data used for this study comes from two data sources, The Cancer Genome
Atlas (TCGA) dataset for colon adenocarcinoma (COAD) and Haraldsplass
Diakonale Hospital (HDH, or HDS in Norwegian) Colon Cancer (CC), denoted
as TCGA and HDS, respectively. For each data source, this study will use both
the mRNA and miRNA raw count signatures for the relevant cohorts. The four
distinctive datasets will thus be refereed to as TCGA mRNA, TCGA miRNA,
HDS mRNA, and HDS miRNA. In addition to the raw counts there are clinical
parameters for each datasets; age, sex, recurrence, overall survival, mismatch
repair status (MMR), and more, that will be used in conjunction with the raw
counts.
Specifically for the TCGA source, there are a number of missing values
pertaining to MMR and microsatellite instability (MSI) status, among others,
leading to a poor comparison between the two. For the purposes of this study,
the MMR status of the HDS cohort will be compared with the MSI status of
the TCGA cohort, given the similar dynamics of the underlying mechanism, and
the fact that the majority of TCGA cohorts have a MSI status. Similarly HDS
defines the recurrence for each patient with a cutoff of 5 years, due to the study
limitation, while TCGA has a 12 year study limitation, and defines instead the
progression free interval (PFI), which should be comparable to the recurrence
parameter of HDS. All patients that have missing information for critically
important parameters as part of the study will be excluded when relevant, see
further discussion when incorporating analysis on the clinical data.
The exact specifications of how the miRNA HDS dataset was recorded can
be found in [24]. The pipeline for mRNA has a similar set of primary proce-
dures. Briefly summarized, samples of the fresh frozen tumor was extracted
using miRNeasy, Mini Kit, and homogenized with Tissuelyzer. The mixture is
purified by DNase treatment and the RNA concentrations are measured using
NanoDrop and quality by Agilent RNA Bioanalyzer. Until the samples were
used, they were stored at −80◦C.
From those samples, the miRNA sequences was converted to a FASTQ for-
mat and the expressions were read using miRDeep2. The mRNA counts were
read using Illumina TruSeq Stranded Total RNA. The reads were aligned with
the human genome GRCh38.p10 using hisat2 and Gencode transcriptome ref-
erence release 26, which was processed with Samtools and FeatureCounts. The
study focused on protein encoding mRNAs. The HDS study was approved by
the Regional ethics Committee according to the Helsinki Declaration.
The pipeline for collecting TCGA samples is outlined here for miRNA and




miRNA mRNA miRNA mRNA
Number of Patients 128 79 416 446
Mean Age 72.05 71.91 67.57 67.73
Relapse True 45 (35%) 20 (25%) 106 (25%) 112 (25%)
Relapse False 83 (65%) 59 (75%) 306 (75%) 334 (75%)
TNM Missing - - 11 (3%) 11 (2%)
TNM 1 18 (14%) 2 (2%) 71 (17%) 75 (17%)
TNM 2 54 (42%) 43 (55%) 159 (38%) 177 (40%)
TNM 3 36 (28%) 34 (43%) 114 (27%) 122 (27%)
TNM 4 20 (16%) - 61 (15%) 61 (14%)
Features Pre Filter 2588 19817 2155 20531
Features Post Filter 900 14261 1206 14427
Feature Intersection 768 (85%) 12021 (84%) 768 (64%) 12021 (83%)
Table 2: Table showing the distribution of clinical information for each of the
four datasets and the size of the feature space (gene pool). The patient numbers
are all patients with a tumor sample after having filtered away patients with
missing Relapse/PFI value. For HDS there are more patients with miRNA than
for mRNA, hence the different in cohort size, while for TCGA it is reversed.
For the purpose of relapse, note that TCGA does not have a relapse parameter,
hence in this table PFI is used synonymously with Relapse. In TCGA there are a
number of features that are missing, and of the cohort used, a small percentage
have no TNM-stage. For the purpose of the analysis these patients will be
included and excluded depending on the specified selected cohort subset. The
last three rows detail the shape of the feature space. The first of the three show
how many features are prior to library size filtering is performed. The second is
the total number of features after said filter. The last is the intersection of the
feature space between the two data sources. The number is the total number of
features, while the percentage is how many of the features of a data source is in
the intersection.
The distribution of clinical data and feature space for each dataset is shown
in table 2. The HDS dataset have considerably fewer samples than the TCGA
datasets. This means learned models on the HDS dataset have a higher risk of
overfitting if the model complexity remains the same on both sets. The mHDS
dataset have considerably fewer stage 1 and 4 patients than the other datasets,
hence why comparison between mTCGA and mHDS would be more comparable
on just stage 2 and 3 samples, see section 3.3 for details on subset selection for
the experiments. There is also a considerable difference in mean age between the
two data sources, 72 in HDS to 67.7 in TCGA. Given that colon cancer patients
are in general old and live for a relatively long time after surgery, the impact of
other factors on a patients help can be relevant for overall survival analysis. The
thesis focuses on the relapse survival, instead of overall survival, but even so, the
relevance of mean age will be discussed in section 4.1. Furthermore, only about
25% of samples have relapse, hence the dataset has a 25 − 75 class imbalance,
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although the miHDS dataset does have slightly more relapse samples. The class
imbalance problem will be briefly touched on in section 3.5.
Lastly, of note, is the difference in the total feature space between the
datasets. The prefiltering, discussed in section 3.4, remove significantly more
features for the miRNA dataset compared to that of the mRNA datasets. This
is even more impactful given that the original feature space is about one tenth
the size. The small feature space in the miRNA intersection between the two
data sources will be briefly touched on in section 3.3.
3.2 Software
The processing of the raw gene counts was done in R using two packages edgeR
[42] and DEseq2 [34]. The former being used for gene expression filtering and
the latter for normalization procedure.
All other code was done in Python3 with a number of relevant packages.
Numpy and Pandas were used to organize the data and perform vectorized op-
erations for data handling. Matplotlib and Seaborn were used to generate all
the graph figures shown in this thesis. Sci-kit learn [39] was used for almost all
machine learning methods used, those being SVM, Random Forest, Gaussian
Naive Bayes, KNN, Decision Tree Classifier, Logistic Regression, and SGD. Ad-
ditionally, the Mutual Information and one-way ANOVA analysis was performed
using Sci-kit learn functions. ReliefF and Fisher was used from the skfeature
module [32] (note that a separate branch of the module called chapper-skfeature
was used) and the attempts at using the Genetic Algorithm to perform subspace
search, see section 4.8, was based on mealpy [50]. Some models, see section 3.3,
was retrained with a random over sampler. The module used for this oversam-
pling was imbalanced-learn [30]. Lastly, survival analysis was done using the
Lifelines module [11].
3.3 Method Overview
The main problem is finding a subset of features that can be used to train a
classifier. The approach of this thesis is to use a number of different feature
selection methods, either wrapper methods training specific classifiers that rank
each feature or filter methods that filter away features based on statistical in-
formation about the feature values. For each of the feature selection methods
a set of features will be selected. However, models could find different num-
ber of relevant features, and models with more features will in general lead to
higher training and validation score, but could lead to poorer generalization
scores, thus the top k number of features from each selector is chosen and ex-
periments are run on each selection of k and compared. The choices for k are
[2, 3, 5, 7, 10, 25, 50, 100, 150, 250]. It should be noted that the figures shown in
section 4 will not show the case for 250 features, given that the trend is apparent
without including 250. Additionally, this means the figures will be of a 3 × 3
grid of subplots, making them more readable.
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Each of the feature selection methods, with a specified number of features k,
is combined into a pool of different feature sets of size k. This pool of different
feature selection methods is used as a hyperparameter in a randomized grid
search for each of the four classification algorithms that are trained, those being
Support Vector Machine, Random Forest, k-Nearest Neighbours, and Gaussian
Naive Bayes classifier. This means that there is one randomized grid search
for each combination of k and model of those four mentioned above. This
exact pipeline can be seen in figure 6. Note that prior to performing feature
selection and/or randomized grid searches, the original counts go through the
normalization procedure that is explained in section 3.4.
The whole pipeline, as outlined in figure 6, is done for each of the datasets
separately. The models that are trained on one data source is then tested on the
other data source to determine if the model generalizes well. Note that to do
this, the feature space has to be the intersection of the feature space of the two
data sources, hence some features are discarded when performing this analysis.
Furthermore, given the different distribution of TNM-stage for the two data
sources, the comparison between the two data sources is primarily done when
looking at only stage 2 and 3 patients. However, all experiments on mRNA
and/or miRNA data uses the intersection of gene pool between the two data
sources, that way a model can be tested on the other data source. Specifically,
the following list details each type of experiment that is done;
• (A) Stage 2 + 3: this experiment is done only on TNM-stage 2 and 3
patients.
• (B) All Stages: this experiment is done with all samples, regardless of
TNM-stage.
• (C) Clinical: this experiment is only done on the clinical information from
the two data sources. Only age, Tumor Stage, Node Stage, Metastasis
Stage, and MMR deficiency are used. Note also that for purely clinical
study, the data used is the highest sample size dataset from each source,
that means comparing miRNA HDS clinical data to mRNA TCGA data.
However, the nature of what dataset the clinical data is collected from has
no importance.
• (D) Stage 2 + 3 Transcriptiom: this experiment is done only on TNM-
stage 2 and 3 samples where the total gene pool from mRNA and miRNA
was combined prior to feature selection.
• (E) Stage 2 + 3 Transciptome + Clinical Data: this experiment combines
clinical parameters with the mRNA or miRNA data post feature selection
for TNM-stage 2 and 3 samples.
Each experiment is trained on one data source and tested on the other data
source to determine if the model has generalized. However, given a specific com-
bination of hyperparameters selected by the randomized grid search, the models
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Figure 6: The figure shows the pipeline for model selection. Raw counts are nor-
malized, then used in a feature selection scheme. A number of models is trained,
or filter methods used, to select a number of relevant features. These sets of
features are stored and used as an additional hyperparameter in the randomized
grid search pipeline. The pipeline for the grid search consists of a dimension
reduction step that selects reduces the gene space of the data to that of one ran-
domly selected feature set (for instance it can select the SVM l1 set of features
or ANOVA or some other) and one model with a random selection of hyperpa-
rameters based on the models hyperparameter space. The model is trained and
scored through cross validation, and the best scoring models for each classifier
is selected. The red lines indicate the iterative process of the randomized grid
search. The line from the clinical data indicates that the transformed normal-
ized counts is concatenated together with clinical parameters, thus the data
used is a combination of genes and clinical information. However, the model
is also trained without the addition of the clinical data, hence why the line is
dotted. Do note that the feature selectors select the k best features, however,
the number k is determined prior to the randomized grid search. This means a
grid search is performed for each combination of classifier model and number of
genes k, where k is selected from a set of predetermined numbers.
are also trained and validated on its own data source. This gives an overesti-
mate of the validation score of that data source due to the whole dataset being
used to determine parameters for the model. The reason for doing so will be
outlined in section 4. This means that for each experiment (five different ones)
all four classification models are optimized in their respective hyperparameter
space for each of the 10 different number of features selected from the different
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feature selection methods. This leads to a high number of possible models that
have been tested, which will be discussed in detail in section 4.
3.4 Preprocessing of Data
The raw counts of the mRNA and miRNA expression has to be normalized
based on its library size, that is the relative magnitude of each gene for a given
patient. This is done through the DEseq2 package as part of R. However, prior
to this normalization step, genes that have a low count will be filtered out, given
that there is an uncertainty in the number of counts.
The filtering used is a function called filterByExpr in edgeR. Genes are kept
if their count-per-million (CPM) are above a threshold for a proportion of the
samples of the smallest sample group and have above a certain minimum total
count threshold. Specifically the minimum count of 70% of the samples must be
10 and the total number counts must be above 15 for all samples. The function
allows for filtering based on the response target, however, it was decided to
not filter based on the response, given that it would bias the filtering on the
response. The principle idea of the filtering is to instead filter away genes that
are too lowly expressed to be considered biological and statistically significant.
The normalization process is done via the DNSeq2, see [34], library us-
ing a Variation Stabilizing Transformation (VST). The VST algorithm aims
to find a differential function h(X) such that the variance of the first degree




du for expectation u and variance v(u) for some randomly dis-




some parameters ai and bi that can be estimated by maximum likelihood. The
full details are described in [22].
After normalizing via VST, the data is then standardized per feature by sub-
tracting the mean and dividing by the standard deviation. This standardization
is done primarily because it improves the performance of a number of machine
learning models, but also because it allows for easier comparison of relevant co-
efficients for feature selection. Additionally, it allows for the SVM classifier to
not stall when using a polynomial kernel function. Given that features with very
little variation prior to this standardization technique can show up has having
more variation post standardization, features that have a low variance should
be filtered out. This, however, is not an issue given that the output of the VST
algorithm has significant variance for all features, hence a variance filter would
not remove any features.
3.5 Methods for Feature Selection
Feature selection was performed using the filter methods described in section
2.4 and wrapper methods using some of the classifiers described in section 2.5.
The filter methods was specifically used to select features based on its score,
not its associated p-value for the null hypothesis. The latter is not used given
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the p-value adjustments selected very few, if any, features, and the main goal is
to analyse the performance with different number of selected features.
For the wrapper method, the following classification models were used as
feature selectors;
• Linear SVM: the linear SVM model was used to extract features with
both l1 and l2 loss. The set of features will be referred to as SVM l1 and
SVM l2.
• Logistic Regression: the logistic regression model was used to extract
features with l1, l2, and elastic-net loss. The models will be referred to
as Log l1, Log l2, and Log net. Note that the Log net model was trained
using stochastic gradient descent, while l1 was with liblinear and l2 was
with lbfgs solvers.
• Stochastic Gradient Descent with Modified Huber Loss: all of l1, l2, and
elastic-net loss was used to extract features with this model. The model
is referred to as SGD l1, SGD l2, and SGD net, however, the use of SGD
specifically means with Modified Huber Loss, given that SGD is simply a
optimization algorithm and not a classifier.
• Random Forest: Random Forest is a ensemble algorithm consisting of
many small decision trees. The feature selection model is referred to as
Rand.
The selected features were based on the coefficients of the model for the
given feature, or in the case of Random Forest, the feature importance. There
are different ways of selecting what features are important, however, for this
study I select the features that have the highest absolute feature importance
or coefficient value. There is some concern with selecting features based on the
magnitude of its coefficients, given features with different magnitudes would
have different magnitudes for its coefficients. However, each feature is standard-
ized to have feature mean zero and standard deviation one, hence no difference
of scale. Given the nature of Random Forest classifier, it will naturally select
a lot of relevant features, even when few features are the only relevant ones.
This means that feature selection on the basis of a Random Forest model se-
lects many features at relatively similar feature importance. Furthermore, the
feature importance tends to favour features that have many unique values.
Additionally, models that are used to for feature selection was trained with
random over sampling of the lower represented response. This was primarily
only relevant for the SGD net and Log l2 models as the models initially strug-
gled with a class imbalance.
3.6 Hyperparameter Space for Classification Models
The following four methods are used as classifiers; soft margin SVM, Random
Forest, KNN, and Gaussian Naive Bayes classifier. Each of the classifiers have a
set of hyperparameters that is searched over during the randomized grid search
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with the exception of the Gaussian Naive Bayes classifier. Below is a list of the
possible hyperparameter spaces for each of the three models with hyperparam-
eters and a brief explained of the impact of said hyperparameter.
For SVM there are a number of hyperparameters that have an impact on
learning. For this thesis, the hyperparameter space is listed below;
• C: the C parameter determine how hard the margin is. Possible options
are 10d for d in [−5,−4,−3,−2,−1, 0, 1, 2, 3].
• Kernel: Kernels introduce non linearity to the otherwise linear estima-
tor. Possible options are Polynomial, Radial Basis Function (RBF), and
Sigmoid.
• Degree (only relevant for polynomial kernel): is the degree of the polyno-
mial kernel. Possible options are 2, 3, 4, and 5.
• Gamma: Gamma determine the relative importance of each datapoint
contribution. The possible options are scale 1mVar(X) , auto
1
m , and 10
d for
d in [−4,−3,−2].
• Class Weight: can either be balanced and none, the former putting weight
on samples according to its class distribution.
The C parameter determines how soft the margin is, a higher value meaning
a more hard margin. The Kernel parameter changes what kernel is used for non-
linear transformation, and the Degree parameter is the degree of non linearity for
a polynomial kernel. The Class Weight parameter determines if the algorithm
compensates for class imbalance or not. Gamma determines the coefficient
for the kernel function. For instance for RBF kernel it would be k(x, xi) =
exp(−γ||x− xi||2).
Secondly, the Random Forest model have the following hyperparameters;
• Impurity Measure: can be either Gini Index or Entropy. Used to determine
selected feature and splitting point for said feature in the Decision Tree
estimators.
• Maximum Depth: the maximum cut off depth of each estimator. The
possible options are none, 1, 2, 5, 8, and 12.
• Number of Estimators: total number of estimators used as part of the
model. Possible options are 2, 5, 10, 25, 50, 100, 250, and 500.
• Class Weight: can either be balanced and none, the former putting weight
on samples according to its class distribution.
The maximum depth parameter determines how shallow each of the estima-
tors are and the number of estimators determine how many such estimators is
used. The impurity measure parameter determines which measure is used to
determine the feature to split, and where to split said feature. Lastly the class
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weight parameter determines if the algorithm compensates for class imbalance
or not.
Lastly, the following hyperparameters are relevant for the KNN model, those
being;
• Number of Nearest Neighbours: the number of nearest points to determine
a classification of a point. The possible options are 1, 2, 5, 7, 10, and 15.
• P: is the power of Minkowski distance, the possible options are 1, 2, and
3.
• Weights: determine the weight each neighbour has when determining a
classification. Possible options are uniform and distance, the former being
equal weight for all neighbours and the latter having the weight be the
inverse of distance to said neighbour.
4 Results
Given the number of experiments conducted and the total number of models
that was trained as part of those experiments, only select subsets of models will
be shown in this section. Section 4.1 will detail the results for Clinical data for
all samples from both TCGA and HDS, and problems related to how models
use certain features. Next section 4.2 and 4.3 will detail the results for Stage 2
+ 3 mRNA and miRNA data and the poor generalization. Possible explanation
of said poor generalization is discussed in section 4.4 in addition to inspection
of specific genes class data distributions. Transcriptome and Clinical data will
be briefly touched on in section 4.6. The details on mRNA and miRNA for all
stages will be presented in section 4.7, and lastly other possible approaches that
was tried and abandoned will be detailed in section 4.8.
The primary goal is to train models on one data source and test it on the
independently sampled other data source to determine if the models generalize
well. Given that there are four possible combinations of training on a data set
and testing it on the other data source
4.1 Clinical Data, Experiment (C)
The clinical variables are MMR status (MSI for TCGA data since there is too
many missing labels for MMR), Age, Tumor stage, Node stage, and Metastasis
stage. The Tumor and Node stage are converted to binary feature vectors via a
OneHotEncoding, leading to a total of eleven features. Figure 7 shows the mean
validation ROC of trained models and the test ROC on the other data source,
the former in dotted lines and the latter in solid lines, for all TNM-stages. Note
that the data used for the figure was mTCGA (n=446) and miHDS (n=128)
clinical data for all cancer stages.
Of the models presented in figure 7, only the SVM models are poorly trained,
reaching the baseline balanced accuracy of 50% despite their ROC curve. This
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Figure 7: The figure shows the mean validation ROC, as a dotted line, and the
test ROC, as a solid line, for both data sources side by side based on Tumor
stage, Node stage, Metastasis stage, Age, and MMR status (experiment (C)).
The training and testing is done on separate data sources. Models trained
on TCGA perform better on HDS than during training on HDS and testing
on TCGA. This is because of its reliance on the Age parameter, which has a
reverse relapse signal in HDS compared to TCGA. Additionally, the TCGA
trained models reach about 70% balanced accuracy, except the SVM model
getting only a 50% balanced accuracy, which is equivalent to only predicting
relapse for all samples. The HDS trained models are between 55 and 66%.
indicates the decision boundary is poorly calibrated and could achieve a better
accuracy if it was tuned better. This is because the ROC curve is based on an
optimal thresholding of probabilities, and given the default probability cutoff of
0.5, the accuracy was markedly lower even if the ROC curve look reasonable.
Furthermore, the model fails to generalize regardless, see section 4.4 on a further
discussion of the differences between the data sources. It should also be noted
that all models are poorly trained on TCGA data, indicated by the dotted
ROC curves near the line of chance. Thus, the model has not been able to learn
anything meaningful from the TCGA data, struggling with the class imbalance
problem.
Take for instance the Random Forest classifier trained on TCGA and tested
on HDS. Despite having really poor validation error it still reaches an AUC
score of 0.83 and a balanced accuracy score of 70%. Figure 8 gives an indication
as to why. The Random Forest algorithm prefers values that have many unique
values (high cardinality), and Age is the only variable with cardinality higher
than 2. As seen in the figure the Random Forest algorithm has a relatively high
feature importance on age, which would explain why it can generalize well on
HDS. The age feature is standardized, i.e. mean zero and standard deviation
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Figure 8: The table shows the feature importance and coefficient for each fea-
ture trained on mTCGA and mHDS clinical data for a Random Forest and
LinearSVM classifier, respectively. mTCGA1 means that the model is trained
without age as a feature, while mTCGA2 means it is trained with age as a
feature. The Random Forest classifier puts a high importance on age over other
features, which is to be expected given the feature has the highest cardinality
out of the feature space. As a matter of fact, all other features have a cardinality
of 2 given they are binary values. The LinearSVM model does not appear to
put equally high importance on age given its coefficients.
one, however, the relapse age distribution might be different between the two
data sources. Figure 9 shows that the relapse signal is reversed in HDS from
TCGA, thus supporting the idea that the model is performing better because of
a difference in the distribution of the cohorts, rather than it necessarily being the
strength of the given feature. Furthermore, the LinearSVM coefficients indicate
other parameters are more important than age, supporting the claim that the
Random Forest classifier selected Age more due to the higher cardinality than
it being a relevant feature. Given that it is only the SVM model that fails of
the four models, it is also possible that Age is a important variable used by
the other two models as well. The important point is Age is the only continues
variable in the clinical data that is used.
Lastly it should be noted that when the analysis is performed only on stage
2 and 3 samples the performance is significantly worse than when using all
samples.
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Figure 9: The figure shows a boxplot of the relapse distribution of normalized
Age clinical feature for both data sources.
4.2 mRNA Stage 2 + 3, Experiment (A)
Consider the mRNA experiment A, as detailed in section 3, involves the inter-
section of gene pool across the two data sources for only stage 2 and 3 patients.
The ROC curves for each model for different number of selected features trained
on mTCGA and testing on mHDS is shown in figure 10. The dotted lines are
the mean validation ROC for the trained models on mTCGA and the solid lines
are the test ROC for those models on mHDS. Note that this specific experiment
has the highest number of training samples of all four possibilities for experi-
ment A, being 299 samples in mTCGA, but equally the smallest test set of 77
samples in the mHDS dataset.
The figure shows, quite naturally so, that the cross validation performance
of the model increases with more features, however, only the SVM model takes
full advantage of all the selected features as the number of features increases,
reaching a near perfect ROC at 150 features, which shows clear signs of overfit-
ting. This can clearly be identified as overfitting given the model has fully fitted
to the underlying training data distribution yet fails to generalize to the other
data source. The poor generalization is not only worse models above the line
of chance, but also models performing well below the line of chance, indicating
that the signal in the test set is different from the training set. A more detailed
43
Figure 10: The figure shows the mean validation ROC on the mTCGA dataset
and the test ROC curves on the mHDS dataset (experiment (A)). Each subplot
contains the ROC curves for models using k number of selected features from
left to right in ascending order. The dotted lines are the mean validation ROC
curves and the solid lines are the test ROC curves on the mHDS dataset. The
plots show a clear failure to generalize from learning on TCGA to predicting on
HDS. Furthermore, some of the test ROC curves are below the line of chance,
indicating that whatever signal was found was found to be reversed in the HDS
dataset.
look at this observation will be discussed in section 4.4.
Beyond the SVM model, the KNN model stalls in cross validation ROC early
at around seven features. Similarly the Random Forest classifier also does not
markedly improve above ten features. It is difficult to discern exactly why the
performance stalls. One possible explentation is that the feature selector used
for that model is poor, however, for 100 features all of SVM, KNN, and GNB
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Figure 11: The figure shows the mean validation ROC on the mHDS dataset and
the test ROC curves on the mTCGA dataset (experiment (A)). Each subplot
contains the ROC curves for models using k number of selected features from
left to right in ascending order. The dotted lines are the mean validation ROC
curves and the solid lines are the test ROC curves on the mTCGA dataset.
selected the same feature selector, namely SVM l1. Yet only the KNN model
fails to improve based on that feature selector. It is possible there is an issue
with the number of iterations for the randomized grid search. The GNB model
has no hyperparameters, so instead it simply selects the best feature selector,
while KNN has a three other hyperparameters it searches over. That being said,
given that this is a consistent pattern for multiple number of features, it might
be related to the model rather than the randomized search.
Both Random Forest and KNN struggle to reach above 60% cross validation
balance accuracy as the number of features increase, while the SVM model reach
upwards of 83% at using 50 features and 72% at seven features. The GNB does
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markedly improve its cross validation balanced accuracy to 76% at 50 features
before plateauing. All models, however, fail to reach above 50% test balanced
accuracy score baring a couple of outliers reaching at most 60%.
A similar pattern can be seen on mHDS trained data tested on mTCGA,
which can be seen in figure 12. The main difference being that the models
general fit better to the training data distribution, however, this is not surprising
given the much smaller sample size.
4.3 miRNA Stage 2 + 3, Experiment (A)
A similar pattern can be seen on the miHDS trained models tested on miTCGA
in figure 12. The distinction being that the models have better validation with
fewer features than in figure 10, yet the poor generalization still persists. Note
that the validation ROCs markedly become worse as more features are added,
especially from 50 to 100 to 150 features. It is possible that the 25 feature model
found a really good combination in the randomized grid search compared to that
of 50, 100, and 150, or it could be equally likely that the additional features
are noise not improving the model. The difference in training sample size is not
significant, the miTCGA dataset consisting of 273 samples, hence that should
not be a driving factor in the different cross validation ROCs compared to that
of the mRNA study.
In summary, the models generalize poorly from TCGA to HDS and HDS
to TCGA for all combinations of datasets, or in some cases generalize to the
reverse relapse signal. A more detailed look at the difference in data distribution
can be seen in section 4.4.
4.4 Difference Between Data Sources
The failure to generalize from TCGA to HDS or HDS to TCGA is interesting to
note. One possible explanation is that the underlying distribution of the data or
the labels are different between the two data sources. Consider firstly figure 13.
The figure shows the Kaplan-Meier survival plot [28] for each data source for
both overall survival (OS) and relapse. There is a definite discrepancy between
the two data sources for both survival and relapse. Consider firstly relapse, as
that is the response parameter for the analysis. There is significantly better
relapse survival for stage 2 for the HDS dataset compared to TCGA and the
relapse survival for stage 3 is worse for HDS compared to TCGA. The relapse
survival for all stages are not that relevant given that the HDS source does not
have any stage 4 patients, hence TCGA stage 4 survival will always be worse.
Next consider the overall survival. Here HDS patients have a higher overall
survival for both stage 2 and 3 compared to that of TCGA.
If there is any possible miss labelling of TNM stages such that samples that
should be stage 1 or 4 are classified as stage 2 or 3, respectively, this should
change the underlying signal given the assumption that cancer acts differently
for different stages and that is detectable with a set of biomarkers. However,
it seems unlikely that there is a mixup between stage 3 and 4, given the clear
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Figure 12: The figure shows the mean validation ROC on the miHDS dataset
and the test ROC curves on the miTCGA dataset (experiment (A)). Each sub-
plot contains the ROC curves for models using k number of selected features
from left to right in ascending order. The dotted lines are the mean valida-
tion ROC curves and the solid lines are the test ROC curves on the miTCGA
dataset. The plots show a clear failure to generalize from learning on HDS
to predicting on TCGA. Furthermore, some of the test ROC curves are below
the line of chance, indicating that whatever signal was found was found to be
reversed in the TCGA dataset.
cut definition of stage 4 by metastasis. Another possibility is that the patients
in the TCGA study happened to have poorer survival conditions post surgery,
however, this is slightly confusing given that TCGA patients are on average 4.5
years younger than HDS patients, and increased age should have a correlation
with other causes for death beyond the cancer itself. The relapse survival could
be impacted by the possible post surgery treatment patients were given, how-
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Figure 13: The figure shows the Kaplan-Meier [28] plots for both overall survival
and relapse free interval for each data source. The subplot structure is setup
such that it compares TCGA with HDS from left to right and data sets and
relapse/survival downwards. The HDS study was limited to five years, while
TCGA was limited to twelve, hence the difference in the charts. Note that only
ten years are plotted for readability. TCGA has better relapse survival than
HDS for stage 3, however, worse for both stage 2 and stage 1. The difference
in all stages comes from the inclusion of stage 4 in the TCGA data which pulls
the relapse survival down. On the other hand the overall survival for HDS is
significantly better than TCGA for stage 2 and 3. It should be noted that the
HDS dataset has very few samples and most patients die of old age rather than
of the cancer, hence the difference in overall survival.
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ever, that would imply whatever treatment the patients in the HDS dataset got
compared to that of TCGA, the outcome was worse in terms of relapse and
better in terms of survival. The standard procedure is to give chemotherapy to
stage 3 patients for those part of the HDS cohort, however, that should in theory
improve the relapse survival, not decrease it, compared to TCGA. That being
said, the exact reasoning for this discrepancy is beyond the scope of this thesis,
however, the difference could explain some of the poor generalization shown
in section 4.2 and 4.3. Lastly, it is entirely possible that the true distribution
of survival lies somewhere in-between the two cases shown above and that the
small sample size leads to a high variance from the true data distribution, or
one would converge to the other with increases sample size.
miRNA mRNA
# Selected Genes (k) Intersection Union Intersection Union
2 0 32 0 27
3 1 40 0 41
5 3 63 0 77
7 4 87 0 112
10 6 114 0 157
25 26 241 3 352
50 77 384 9 637
100 189 587 26 1153
150 330 680 58 1654
250 572 755 158 2542
Table 3: The table shows the intersection and union of genes over all
possible feature selector of size k for both data sources for a given data
type (mRNA and miRNA). Formally the intersection is interk(mRNA) =∣∣{∪Fi=1Geneski (mTCGA)} ∩ {∪Fi=1Geneski (mHDS)}∣∣ where Geneski (mTCGA) is
the specific selected gene names for gene selection method i that selects k num-
ber of genes. The union columns are defined similarly with a ∩ instead of ∪
between the two sources.
Another consideration is if there are features that are found in feature se-
lection on both data sources. Table 3 shows the number of genes in the in-
tersection and union of gene pool from the two data sources over all possi-
ble feature selector methods. Formally the intersection is interk(mRNA) =∣∣{∪Fi=1Geneski (mTCGA)} ∩ {∪Fi=1Geneski (mHDS)}∣∣ where Geneski (mTCGA) is
the specific selected gene names for gene selection method i that selects k number
of genes. The total number of different selection methods is detailed in section
3. This table does not account for how relevant a given feature is, only that at
least one of the given models deems the feature important. The consequence
of such a lax constraint is that features that have a considerable importance
for both data sources are valued equally as features that are just tangentially
relevant for a single feature selector. However, this the lax criteria is on purpose
to see if there exists any overlap at all, no matter how insignificant.
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Figure 14: The figure shows a table of the presence of a given gene in feature
selectors for a k equal to 3, 5, and 7. The presence column indicate the pro-
portion of feature selectors that selected said feature and the presence other is
the proportion of feature selectors that selected said feature in the other data
source. Specifically, take the top table, TREML2 has a presence of 0.857 in
mTCGA and 0 in mHDS. Similarily RAD17 has a 0.571 presence in mHDS and
0 presence in mTCGA. For each dataset the genes are sorted by their presence.
Only the k + 1 top features are shown. The tables show that the presence of
mRNA genes is not replicated in the other data source, while for miRNA genes
there is some moderate presence in the other data source.
The table clearly shows that there is virtually zero overlap for mRNA and
some overlap for miRNA. The overlap for miRNA quite likely comes from the
fact that there are ten times fewer features in the miRNA dataset compared to
the mRNA datasets. The lack of overlap helps explain why the models generalize
poorly, since the genes found in one data source do not hold predictive power
in the other source.
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Instead of looking at just the size of the intersection of genes, consider figure
14 that shows a list of the top k+1 number of genes ranking by what percentage
of feature selectors the given feature is selected in. The figure shows feature
selectors of size three, five, and seven.
Figure 15: The figure shows the boxplot distribution for relapse and no relapse
for each mTCGA and mHDS for a select number of features. The blue plots
are for mTCGA and orange for mHDS. The box represents the middle 50% of
the data and the line through it the median. The whiskers represent the outlier
boundary and the outliers are indicated as data points. The first row of figures
show the distribution for the three genes that have the highest presence in the
mTCGA feature selectors for 3 < k < 25. Similarity the second row are genes
that are prominent in the mHDS feature selectors. The range of 3 < k < 25
was selected because that is roughly the range of desirable number of features
for a model. A higher k would also median that genes that have a very weak
signal that many models could pick up would be part of the list.
Another possible approach to identifying the poor generalization is to look
at the data distribution of each class for both data sources for features that are
selected to perform well, see figure 15. This can be shown as a boxplot, i.e. a
box showing the 25-75 percentile and the whiskers showing the boundary for
outliers, < 5 percentile or > 95 percentile, side by side. Note that the class
data distribution is shown, instead of the feature distribution, since what is
important is how the data is distributed for each class comparatively instead of
the total data distribution, which is, given the standardization step, mean 0 and
standard deviation 1. If a feature has the same predictive signal across both data
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Figure 16: The figure shows the boxplot distribution for positive and negative
relapse for each miTCGA and miHDS for a select number of features. See figure
15 for a more detailed description of the figure type.
sources it should have the same signal distribution. I.e. if a gene is positively
correlated with relapse, then it should still be positively correlated with relapse
in the other data source. If the other data source has a negative correlation, that
would explain why predictions can be flipped, as a negative correlation would
simply mean it is correlated with no relapse instead of relapse. If the relapse
distribution is not markedly different from the no relapse distribution, i.e. the
50 quantile is quite wide and intersects the domain of the relapse 50 quantile,
then the feature is simply inconclusive and can lead to false positives and false
negatives, rather than simply almost always predicting the wrong class.
Consider figure 15. The TREML2 gene, which is among the highest presence
in mTCGA feature selectors, show exactly how the signal of the two data sources
can be different. TREML2 is negatively correlated with relapse in mHDS while
it is positively correlated in mTCGA. This means that models that rely on
TREML2 will not generalize well on mHDS samples. However, CASPER3 have
relatively the same signal for relapse for both data sources, albeit the total
spread of relapse samples are smaller than for non relapse samples. There is a
small difference between the two data sources given that CASPER3 is slightly
positively correlated with relapse in mHDS, but it is nowhere near as stark of a
difference as for TREML2. Another problem with CASPER2 is that the class
distribution within a single data source is not that different. The mean and
spread of mTCGA is relatively similar, even if the outliers are slightly more
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spread out for non relapse samples. Genes that follow this general distribution
would be a poor univariate estimator compared to that of TREML2. This is
important because not all genes that a feature selector selects are part of a
feature selector set. For instance if SVM l1 selects TREML2 and another gene,
that combined are have better predictive power than alone, the two genes need
not be a part of the feature set with k number of features. On the second row
both RAD17 and SHQ1 show a similar pattern to TREML2 in that the signal
is vastly different between the two data sources. Note that the second row are
genes that the feature selectors deem relevant on the mHDS dataset, hence the
negative correlation with relapse is what the feature selectors deemed relevant.
Figure 16 shows the boxplot for six selected miRNAs. Note that, unlike for
mRNA, the miRNA ”hsa-miR-656-3p” has a high presence in both data sources,
but the other five have no presence on the opposite data source feature selection
pool. It is interesting that this gene is important for both selectors given the
class signal appears identical for relapse and non relapse samples for miTCGA.
Another thing to note is that the relapse distributions for ”hsa-miR-146a-3p”
have a mean at the lowest point of the distribution. A similar pattern can
be seen for ”hsa-miR-686-3p”, but for non relapse samples instead of relapse
samples.
4.5 mRNA + miRNA for Stage 2 + 3, Experiment (D)
Next consider the experiment of combining both mRNA and miRNA into a
single feature space. This does slightly increase the dimensionality relative to
just mRNA, however, the increase is marginal at best, about a 6% increase
at most. This allows the feature selector to find combinations of mRNAs and
miRNAs that help explain the relapse distribution. This experiment was done
only on TNM-stage 2 and 3 sample.
Figure 17 show the results of training on TCGA data and testing on HDS.
The figure shows the same pattern of models increasing cross validation ROC as
the number of features increases, however, it does show that the generalization
actually improves with more features, specifically becoming markedly better at
25 features. This indicates that there is at least some congruent relapse signal
between the two data sources, even if it does mean both mRNAs and miRNAs
have to be included to find such a signal. Additionally, the KNN continues to lag
behind the other models, presumably struggling with noisy additional features
as the number of selected features increases. Even if the test ROC curves do
improve with more features, the balanced accuracy measure remains mostly
unchanged, hovering around the baseline of 50% indicating that the default
probability decision boundary could be tuned such that the model performs
better. On the other hand figure 18 show that the strong cross validated signal
that is found in HDS is not replicated when testing on TCGA, and the balanced
accuracy measure is no better either.
That being said, figure 19 show that the features that are selected is a mix
of mRNAs and miRNAs, note the different naming convention for miRNAs
including a ”miR” part and/or ”-3p” or ”-5p” suffix. However, the figure also
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Figure 17: The figure shows the mean validation ROC on the combined TCGA
dataset and the test ROC curves on the combined HDS dataset. Combined
means that the feature space from the mRNA and miRNA datasets have been
concatenated prior to feature selection. Each subplot contains the ROC curves
for models using k number of selected features from left to right in ascending
order. The dotted lines are the mean validation ROC curves and the solid lines
are the test ROC curves on the HDS dataset. The plots show a clear failure to
generalize from learning on HDS to predicting on TCGA.
shows that the presence in the other data source remains non existent, hence
partially explaining why the HDS trained models fail to generalize on TCGA
data.
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Figure 18: The figure shows the mean validation ROC on the combined HDS
dataset and the test ROC curves on the combined TCGA dataset (experiment
(D)). Combined means that the feature space from the mRNA and miRNA
datasets have been concatenated prior to feature selection. Each subplot con-
tains the ROC curves for models using k number of selected features from left to
right in ascending order. The dotted lines are the mean validation ROC curves
and the solid lines are the test ROC curves on the TCGA dataset. The plots
show a clear failure to generalize from learning on HDS to predicting on TCGA.
4.6 mRNA or miRNA Combined with Clinical Data, Ex-
periment (E)
Experiment E combines a dataset with the clinical parameters after performing
feature selection, and a model is trained on the new feature space. The best
performing dataset in terms of generalization is shown in figure 20. The figure
shows that the Gaussian Naive Bayes classifier reaches a peak performance near
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Figure 19: The figure shows a table of the presence of a given gene in feature
selectors for a k equal to 3, 5, and 7 when the mRNA and miRNA data is
concatenated prior to feature selection. The presence column indicate the pro-
portion of feature selectors that selected said feature and the presence other is
the proportion of feature selectors that selected said feature in the other data
source. For each data source the genes are sorted by their presence. Only the
k + 1 top features are shown.
7 features, reaching a 70% imbalanced accuracy score, markedly better than any
of the other trained models, however, even a 2 feature model still perform almost
equally as well. This indicates that it is possible adding clinical parameters to
the data would improve the model, however, this pattern does not repeat for
any other model, nor for any other dataset, thus making the inclusion dubious.
This is further supported by the clear difference in age, which has been shown
to allow models to generalize better from TCGA to HDS.
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Figure 20: The figure shows the mean validation ROC on the combination of
mTCGA data and clinical data after feature selection has been performed on
mTCGA data (experiment (E)). Each subplot contains the ROC curves for
models using k number of selected features from left to right in ascending order.
The dotted lines are the mean validation ROC curves and the solid lines are the
test ROC curves on the mHDS dataset.
4.7 Transcriptome Data All Stages, Experiment (B)
Lastly, consider the case for mRNA and miRNA data for all stages. Despite
increasing the sample size when including stage 1 and 4 samples, the models
remain mostly unchanged performing near the line of chance. One of the four
cases, trained on TCGA and tested on HDS, is shown in figure 21. Of the
four datasets, this is the highest performing generalization ROC, however, the
models have poor balanced accuracy score near the baseline of 50%. The other
cases are not shown, given the case shown in figure 21 is the best case scenario
for experiment (B).
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Figure 21: The figure shows the mean validation ROC on the mTCGAA dataset
and the test ROC curves on the mHDS dataset for all TNM stages (experiment
(B)). Each subplot contains the ROC curves for models using k number of
selected features from left to right in ascending order. The dotted lines are the
mean validation ROC curves and the solid lines are the test ROC curves on the
mHDS dataset.
4.8 Other Attempted Methods and Experiments
There are other factors than mRNA and miRNA that might be relevant to re-
currence, one of which being the proportion of different cell types present in a
tumor sample. The following researches have compiled a number of methods to
calculate the infiltration estimate, i.e. proportion of cells within a tumor, for
all TCGA datasets [31]. There is also a possibility of predicting the infiltration
estimate for new datasets as well as part of their website TIMER2.0. The infil-
tration estimates are based on a number of different methods and have potential
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Figure 22: The figure shows the mean validation ROC for models trained on
both clinical data and each of the seven different infiltration estimate models
individually for each subplot.
to being relevant as an additional datapoint to clinical data, however, the few
experiments that was conducted on the TCGA data did not yield and signifi-
cant results and models struggled with the class imbalance, hence the approach
was scrapped. Figure 22 shows the preliminary results of those experiments,
showcasing the models not finding any relevant signal. Note that there is no
test set for this analysis given that the infiltration estimate for HDS was not
available.
Another approach for feature selection was to use a Genetic Algorithm to
select subsets of features that was used to train SVM models with l1 weight
decay as a means to perform SVM l1 feature selection on subselections of the
total feature space. This appraoch was also scrapped due to problems with the
initialization of the subsets and having the algorithm properly explore a wide
subset of features. The models instead just hovered around the same feature
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space or simply expanded to include more features, which was not conducive.
The approach was based on a paper using Grasshopper Optimization as a meta-
heuristic learning approach to feature selection [47].
5 Concluding Remarks and Future Work
The results for the trained models on one data source shows a failure to gener-
alize to the other. In the few cases where there are some reasonable test ROC
curves, the predictions are still off, meaning that the probability decision bound-
ary needs to be tweaked. Combining both mRNA and miRNA before performing
feature selection yields better generalization for the downstream models, even if
the presence across data sources for said selected features remain non existent.
Combining transcriptome and clinical data show some promise for one model
when trained on mTCGA and tested on mHDS, however, all other datasets
fail. The best models were trained on clinical data in terms of generalization
performance, however, that can be questioned given the reliance on age. Three
problems have been identified in this study something something The problems
can be summarized in three key points 1) opposite or different signals between
the two data sources, 2) single step feature selection, and 3) class imbalance.
Problem 1) is shown in figure 15 and discussed at length in section 4.4.
This is related to how the data was collected, how it was preprocessed before
the analysis, or possibly that the features found are not important. Given the
relative uncertainty here it might be beneficial to perform the same analysis
on a different data source to determine if the same pattern repeats. The paper
[43] performed non-negative matrix factorization on mRNA data from two Gene
Expression Omnibus (GEO) [12] datasets that were uploaded to the National
Center for Biotechnology Information (NCBI) website related to the following
two papers [27] and [26]. Alternatively an analysis could be performed on some
library adjusted raw count values to determine if these genes have a different
relapse signal before the normalization step.
Problem 2) is the single step feature selection technique that has a weakness
to overfitted wrapper models. With a sufficient number of features from an
overfitted wrapper model, a model trained on said features could replicate the
existing overfitted model. There are some indications of this for the SVM model,
however, it is not a consistent problem. Additionally, the filter methods also
struggle to find statistically significant features based on the adjusted p-values,
hence why the k most important features are selected instead.
One remedy could be to perform a nested feature selection approach. Use the
filter based method to filter down to a large number of features, then take the
union over those feature spaces, and perform wrapper methods on that reduced
feature space. The advantage of this approach is that the wrapper methods
have less features to heavily overfit on and the subset selection can be based on
forward/backward selection methods instead of a single trained model.
In section 4.8 a Genetic Algorithm [40] approach that was abandoned due
to time constraints was mentioned. This type of approach to explore the full
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feature space via smaller subspaces of features that are selected based on a
metaheuristic could prove powerful as a feature selector. This would be similar
to how Random Forest reduces bias by randomizing features for each of its
estimators, albeit the difference being that a specific estimator is selected over
using all of them in an ensemble. However, the latter could be possible. Consider
a ranking system of each feature based on its importance in a model and the
relative performance of its associated wrapper method, then use the combined
score over the whole feature space to determine good features. One problem
with such an approach is that good features would be drowned out by the many
bad features unless proper care is taken to account for model performance based
on the given features.
Sharifai and Zainol [47] used a grasshopper optimization algorithm to select
subsets of features that was used to train individual SVM models to select
features. Many other metaheuristic approaches could be applied as well, many
of which are implemented in the mealpy python package for use [50].
Regardless of how feature selection is performed, it is important to note
that for mRNA data there is a huge feature space compared to the sample
space, hence models for feature selection needs to take this into account. Even
a set of filter methods into wrapper methods on the union still runs into the
high dimensionality problem for the filter methods. Approaches like a genetic
algorithm, or other metaheuristics, still need to explore a relatively large feature
space and models need to be properly penalized for using unimportant features.
Lastly, from problem 3), the class imbalance problem could be partially al-
leviated by performing random over-sampling when performing the randomized
grid search to determine optimal hyperparameters. It should be noted that
with sufficiently small feature spaces, it is also possible to perform SMOTE or
ADASYN sampling, however, care should be taken to the bias in the oversam-
pling, see [30]. The same could be said for random over sampling, which simply
duplicates data samples.
For future work I recommend using additional datasets from the GEO database
to determine if the difference in gene expression exist for those datasets as well.
If that fails suggest using gene mutation or DNA methylation data which is
available for both TCGA and HDS as additional sources of information. The
methods fail on the mRNA and miRNA data because there is a difference in the
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